<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
	<channel>
		<title>Chemicals</title>
		<link>http://emediaworld.com/press_release/rss/rss_62.xml</link>
		<description>Chemicals</description>
		<language>en-us</language>
		<lastBuildDate>Mon, 05 Jan 2009 17:02:51 EST</lastBuildDate>
		<item>
			<title><![CDATA[Treaty Petroleum, Inc. and Alternate Energy Corp. Announce Merger]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=307087</link>
			<pubDate>Fri, 26 Dec 2008 06:30:00 EST</pubDate>
			<description><![CDATA[Treaty Petroleum Merged into Alternate Energy Corp. on December 24th -- Alternate Energy Corp. Will Change Name to Treaty Energy Corporation on or About December 29th]]></description>
		</item>
		<item>
			<title><![CDATA[OctoPlus wins new technology evaluation contract]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=305215</link>
			<pubDate>Mon, 22 Dec 2008 01:50:00 EST</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - December 22, 2008) -  As part of the Company&#039;s recently
announced strategic focus on using
its controlled release technology for clients, OctoPlus N.V.
(&quot;OctoPlus&quot; or &quot;the Company&quot;) (Euronext: OCTO) announces today that
it has signed a new technology evaluation contract with a large
UK-based company.

OctoPlus&#039; strategy will increasingly focus on developing controlled
release versions of existing or new drugs for clients, in addition to
providing general formulation development and clinical material
manufacturing. Currently, OctoPlus is working on six projects
utilising its controlled release technology for a client.
]]></description>
		</item>
		<item>
			<title><![CDATA[DSM and Crucell Announce PER.C6(R) Research License Agreement with GSK]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=303205</link>
			<pubDate>Thu, 18 Dec 2008 02:01:00 EST</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - December 18, 2008) -  Leiden, The  Netherlands/Parsippany,
USA,  18 December  2008  -  DSM
Biologics, a business unit of DSM Pharmaceutical Products, and  Dutch
biopharmaceutical company Crucell N.V. (Euronext, NASDAQ: CRXL) (SWISS: CRX), today announced  that GlaxoSmithKline (GSK) signed  a
license agreement allowing GSK to  research a recombinant protein  on
the PER.C6&reg;  platform. Financial  terms  of the  agreement  were  not
disclosed.
]]></description>
		</item>
		<item>
			<title><![CDATA[AMNE Announces Record Date for Preferred]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=302959</link>
			<pubDate>Wed, 17 Dec 2008 12:30:00 EST</pubDate>
			<description><![CDATA[NEW HAVEN, CT--(eMediaWorld - December 17, 2008) -  American Green Group, Inc. (PINKSHEETS: AMNE)
announced today that it has selected January 23, 2009 as the record date
for the preferred stock dividend announced a few weeks ago.  This will give
the Company plenty of time to close the Paradigm transaction and create the
new Preferred to be used as the dividend.

AMNE will be creating a special class of Preferred stock that will be
issued to all shareholders of record on January 23, 2009, the record date.
The Preferred shares can be converted into common stock after One year at
the rate of Five Common shares for every One Preferred redeemed. AMNE shall
issue One Preferred for every 20 shares of Common owned on the record date.
]]></description>
		</item>
		<item>
			<title><![CDATA[AMNE Releases New Web Site and Works to Close Paradigm Deal in 2008]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=302657</link>
			<pubDate>Wed, 17 Dec 2008 09:17:00 EST</pubDate>
			<description><![CDATA[NEW HAVEN, CT--(eMediaWorld - December 17, 2008) -  American Green Group, Inc. (PINKSHEETS: AMNE)
announced today that its new web site, www.amneotcpk.com, is up. AMNE will
continue to add content as the company grows over the next several months.
AMNE&#039;s wholly owned subsidiary, Eco-Built Systems, LLC (&quot;ECO-BUILT&quot;), has
been exchanging information with Paradigm Polymers, Inc., in an effort to
close the transaction this year. Terry Mixon is in Georgia meeting with
Gary Gray to discuss the and finalize the Purchase Agreement.
]]></description>
		</item>
		<item>
			<title><![CDATA[Crucell Signs Second Exclusive License Agreement with Talecris Biotherapeutics]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=302658</link>
			<pubDate>Wed, 17 Dec 2008 08:11:00 EST</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - December 17, 2008) -  Leiden, The Netherlands (December 17,
2008) - Dutch biopharmaceutical
company Crucell N.V.  (Euronext, Nasdaq: CRXL;  Swiss Exchange:  CRX)
today announced that  it has  signed a  second exclusive,  commercial
license agreement with North Carolina-based Talecris  Biotherapeutics
for an undisclosed and specific  protein and the exclusive rights  to
produce that protein using the PER.C6&reg; cell line.

Crucell will receive an upfront payment of $1.5 million following the
execution of  the  agreement  and  will  be  eligible  for  milestone
payments of approximately $20  million. Further financial details  of
the agreement were not disclosed.
]]></description>
		</item>
		<item>
			<title><![CDATA[iDcentrix Expands Its Presence in the Caribbean &amp; Central America Through Partnership With Sysconis]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=302659</link>
			<pubDate>Wed, 17 Dec 2008 08:00:00 EST</pubDate>
			<description><![CDATA[LOS ANGELES, CA--(eMediaWorld - December 17, 2008) -  iDcentrix (OTCBB: IDCX) today announced it
has signed a teaming agreement with Sysconis, a leading IT consulting and
services integration company specializing in identification system
platforms, to jointly market identity products and services in Puerto Rico,
the Dominican Republic and Costa Rica. Terms were not disclosed.

The agreement is focused on offering government organizations in the
region&#039;s state-of-the-art technology that assures the integrity of
identification cards such as drivers&#039; licenses, voter identification cards
and other associated documents.
]]></description>
		</item>
		<item>
			<title><![CDATA[[Video] Wall St. Network&#039;s 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: EXOU, N, FHC, PHEI]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=302660</link>
			<pubDate>Wed, 17 Dec 2008 07:00:00 EST</pubDate>
			<description><![CDATA[NEW YORK, NY--(eMediaWorld - December 17, 2008) -  Wall St. Network&#039;s 3-Minute Press Show is a
daily program hosted by WSN reporter Tracee Tolentino that features
in-depth interviews with public company executives on their company and
most recent press releases.

The show is designed to provide viewers with insight into a company&#039;s
latest news, and its impact on the company&#039;s growth.

Shows air Monday through Friday at:
http://tv.wallst.net/3-min-press/3-min-press.php.
]]></description>
		</item>
		<item>
			<title><![CDATA[[Video] Wall St. Network&#039;s 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: EXOU, DRI, SKNN, and SKPN]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=302661</link>
			<pubDate>Wed, 17 Dec 2008 07:00:00 EST</pubDate>
			<description><![CDATA[NEW YORK, NY--(eMediaWorld - December 17, 2008) -  Wall St. Network&#039;s 3-Minute Press Show is a
daily program hosted by WSN reporter Tracee Tolentino that features
in-depth interviews with public company executives on their company and
most recent press releases.

The show is designed to provide viewers with insight into a company&#039;s
latest news, and its impact on the company&#039;s growth.

Shows air Monday through Friday at:
http://tv.wallst.net/3-min-press/3-min-press.php.
]]></description>
		</item>
		<item>
			<title><![CDATA[Reon(TM) Starch-Based Ingredients Provide Effective, Sustainable Fluid Management Solutions for Industrial Products]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=302378</link>
			<pubDate>Tue, 16 Dec 2008 20:17:00 EST</pubDate>
			<description><![CDATA[BEAVERTON, OR--(eMediaWorld - December 16, 2008) -  Industrial product engineers seeking
high-quality, sustainable products now have access to a superabsorbent
ingredient made from corn starch.

Marketed under the name ReonT, the superabsorbent is capable of
retaining 500 times its weight in water, and is designed to manage water
and fluids in a wide range of industrial products and applications.  Uses
for Reon are being expanded by Absorbent Technologies, Inc. (ATI), a
private company that has taken global leadership in developing sustainable
starch-based superabsorbent polymers.  The company recently enlarged its
Albany, Ore. plant to prepare for growth in industrial applications.
]]></description>
		</item>
		<item>
			<title><![CDATA[Universal Systems Provides Update]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=299873</link>
			<pubDate>Fri, 12 Dec 2008 09:00:00 EST</pubDate>
			<description><![CDATA[BAKER CITY, OR--(eMediaWorld - December 12, 2008) -  Universal Systems, Inc. (PINKSHEETS: UVSS)
is very pleased to announce today that it had a long successful trip to
Canada this past week. Our lead scientists and managers met with top
managers and executives of 7 major oil and oil field service companies
which included Enerchem, Suncor, EnCana, Petro-Canada, ERS, Sun Crude, and
ERCD, an Alberta Government Agency.

These meetings have landed Universal Systems, Inc. preliminary lab work,
which once completed, will allow us to go forward on building long term
relationships. The overwhelming audience with these groups allowed
Universal to demonstrate its ability to deal with their major water issues,
one being that of a method to clean up produced water that is continually a
problem that occurs when you have a producing oil well and secondly, KCL
water which is produced when an oil well is being acidized to increase]]></description>
		</item>
		<item>
			<title><![CDATA[Crucell Announces Excellent Results for Influenza Antibody]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=299001</link>
			<pubDate>Thu, 11 Dec 2008 02:00:00 EST</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - December 11, 2008) -  Dutch  biopharmaceutical
company Crucell N.V.  (Euronext, NASDAQ: CRXL)  (SWISS: CRX)
today announced that its monoclonal antibody (mAb) directed against a
broad range of influenza virus strains has strongly outperformed  the
most current anti-influenza drug in preclinical tests.

The latest results were presented yesterday, by Dr Jaap Goudsmit,  at
IBC&#039;s 19th Annual International Conference on Antibody Engineering in
San Diego, USA. The preclinical  study compared Crucell&#039;s mAb  CR6261
with the anti-influenza drug oseltamivir in terms of their value  for
flu prevention and treatment.
]]></description>
		</item>
		<item>
			<title><![CDATA[Agrium Curtails Production, Provides Guidance Update]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=297930</link>
			<pubDate>Tue, 09 Dec 2008 21:04:00 EST</pubDate>
			<description><![CDATA[CALGARY, ALBERTA--(eMediaWorld - Dec. 9, 2008) - 

ALL AMOUNTS ARE STATED IN U.S.$

Agrium Inc. (TSX:AGU) (NYSE:AGU) announced today that it has shut-in production at its Fort Saskatchewan nitrogen facility and has further curtailed production at other major nitrogen and phosphate plants in North America. The temporary curtailments are necessary due to a significant build in North American fertilizer inventories and declining available storage capacity.

Global nutrient and crop prices have weakened since early November when our second half guidance was issued and deferral of wholesale nutrient purchases has been significant. This has resulted in further sales volume reductions and production curtailments that will affect earnings contributions from our Wholesale business unit.

]]></description>
		</item>
		<item>
			<title><![CDATA[AMNE Begins New Direction]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=296943</link>
			<pubDate>Tue, 09 Dec 2008 09:18:00 EST</pubDate>
			<description><![CDATA[NEW HAVEN, CT--(eMediaWorld - December 9, 2008) -  American Green Group, Inc. (PINKSHEETS: AMNE)
is beginning to move forward with its news business model as a distributor
of Chemicals in the $6 Billion Dollar Insulation market.  On December 3,
2008 a Board Resolution was signed officially terminating John Cangiano as
the CEO and President of AMNE and appointed Terry Mixon as the new CEO and
Chairman of the Board.  As part of the rescission agreement all the shares
issued for the purchase of AES have been returned to the company which
would include 35 million shares of Common stock and 11,500 shares of Series
AA Preferred Stock, AES shall no longer be a wholly owned subsidiary of
AMNE as of December 15, 2008.
]]></description>
		</item>
		<item>
			<title><![CDATA[PhosCan Chemical Corp.: Martison Phosphate Project Development Update and Announcement of Special Meeting of Shareholders]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=295074</link>
			<pubDate>Mon, 08 Dec 2008 08:30:00 EST</pubDate>
			<description><![CDATA[TORONTO, ONTARIO--(eMediaWorld - Dec. 8, 2008) - PhosCan Chemical Corp. (TSX VENTURE:FOS) announces an update on the development of the Company&#039;s wholly-owned Martison Phosphate Project and a special meeting of PhosCan shareholders.

Martison Phosphate Project Update 

Subsequent to the previous update of July 31, 2008, the Company has completed the following activities related to the development of the Project:

- Upgrade of the Fox River crossing and the existing Fushimi road; this work was completed by a construction company in a joint venture with a local First Nation

]]></description>
		</item>
		<item>
			<title><![CDATA[Dow Chemical and Kuwait&#039;s Petrochemical Industries Finalize Joint Venture at Lower Value, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=295076</link>
			<pubDate>Mon, 08 Dec 2008 06:00:00 EST</pubDate>
			<description><![CDATA[BANGALORE, INDIA--(eMediaWorld - December 8, 2008) -  Researched by Industrial Info Resources
(Sugar Land, Texas) -- A joint-venture agreement between Kuwait&#039;s
state-owned Petrochemicals Industries Company (Safat) and Dow Chemical
(NYSE:DOW) (Midland, Michigan) has been finalized, albeit at a lower value.
Both companies will have a 50% stake in the new joint venture company,
K-Dow Petrochemicals.

For details, view the entire article by subscribing to Industrial Info&#039;s
Premium Industry News at
http://www.industrialinfo.com/showNews.jsp?newsitemID=141840, or browse
other breaking industrial news stories at www.industrialinfo.com.
]]></description>
		</item>
		<item>
			<title><![CDATA[Crucell Announces Registration of Hepavax-Gene(R) in China]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=295077</link>
			<pubDate>Mon, 08 Dec 2008 01:53:00 EST</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - December 8, 2008) -  Dutch  biopharmaceutical
company Crucell N.V. (Euronext,  NASDAQ: CRXL; Swiss Exchange:  CRX),
today  announced   that  the   Chinese  Authorities   have   released
Hepavax-Gene&reg; for registration and quality control in China.

&quot;The launch  of Hepavax-Gene&reg;  is a  significant advancement  in  the
expansion of  Crucell&#039;s  business  in the  highly  strategic  Chinese
vaccine market,&quot; said Ronald Brus, Crucell&#039;s Chief Executive Officer.
&quot;Hepavax-Gene&reg; will contribute significantly to the sustainability of
our Chinese operations. The Chinese hepatitis B vaccine market is the
world&#039;s  biggest  market   with  approximately   100  million   doses
administered yearly.&quot;
]]></description>
		</item>
		<item>
			<title><![CDATA[Multiple Year Data Confirms Advantage of Monsanto YieldGard VT Triple(TM) Technology on Rotated Ground]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=291085</link>
			<pubDate>Wed, 03 Dec 2008 11:45:00 EST</pubDate>
			<description><![CDATA[GUELPH, ONTARIO--(eMediaWorld - Dec. 3, 2008) - The results are in and for a second consecutive year Monsanto&#039;s YieldGard VT Triple hybrids proved that it pays to use Monsanto corn technology on rotated ground. Multiple year data confirms YieldGard VT Triple corn provides a yield advantage on rotated ground relative to products without protection against corn rootworm from the same genetic family. Over two years and 155 sites, YieldGard VT Triple has a yield advantage, on average, of 2.8(i) bushels per acre on rotated ground.

]]></description>
		</item>
		<item>
			<title><![CDATA[Alternate Energy Corp. Announces Letter of Intent for the Merger of Treaty Petroleum, Inc. With a Wholly-Owned Subsidiary of Alternate Energy]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=291086</link>
			<pubDate>Wed, 03 Dec 2008 09:40:00 EST</pubDate>
			<description><![CDATA[BURLINGTON, ON--(eMediaWorld - December 3, 2008) -  Alternate Energy Corp. (OTCBB: ARGY)
announced today that it has entered into a Letter of Intent (LOI) with
Treaty Petroleum, Inc. pursuant to which Treaty will merge with a
wholly-owned subsidiary of Alternate Energy.  In consideration of the
merger, the shareholders of Treaty would receive at the closing a number of
shares of Alternate Energy&#039;s common stock, which upon issuance would
represent 90% of Alternate Energy&#039;s outstanding common stock.  Upon
completion of the merger, the surviving public company&#039;s name will be
changed to Treaty Energy Corporation.
]]></description>
		</item>
		<item>
			<title><![CDATA[McGladrey Capital Markets Leads Negotiations as Halltech Completes Management-Led Buyout]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=289215</link>
			<pubDate>Tue, 02 Dec 2008 10:00:00 EST</pubDate>
			<description><![CDATA[COSTA MESA, CA--(eMediaWorld - December 2, 2008) -  Scarborough, Ontario-based Halltech Inc.,
the Canadian subsidiary of Japan-based Saiden Chemical Industry Co., has
completed a management-led buyout of the firm. Transaction terms were not
disclosed.

McGladrey Capital Markets LLC led the negotiations and acted as exclusive
financial advisor to Saiden. Davis LLP acted as the legal advisor to
Saiden.

The sale of Halltech allowed Saiden to restructure its North American
operations and place greater focus on its North Carolina subsidiary as a
growth platform. In addition, this transaction enables Saiden to reinvest
its financial and management resources in high-growth East Asian markets.
]]></description>
		</item>
		<item>
			<title><![CDATA[AMNE Issues Further Updates]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=289216</link>
			<pubDate>Tue, 02 Dec 2008 09:32:00 EST</pubDate>
			<description><![CDATA[NEW HAVEN, CT--(eMediaWorld - December 2, 2008) -  American Green Group, Inc. (PINKSHEETS: AMNE)
is pleased to announce that as of December 15, 2008 American Energy Savers,
Inc. will no longer be part of American Green Group. The transaction that
took place earlier this year has been rescinded as of December 15, 2008.
Once completed, all the Preferred shares issued for the transaction shall
be canceled and returned to the Company, which includes 35 million shares
of issued and outstanding Common Stock which had been converted from the
Preferred Stock.
]]></description>
		</item>
		<item>
			<title><![CDATA[EnerTeck Corporation Announces the Beginning of a Major Performance Demonstration for the Railroad Industry]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=289218</link>
			<pubDate>Tue, 02 Dec 2008 09:00:00 EST</pubDate>
			<description><![CDATA[STAFFORD, TX--(eMediaWorld - December 2, 2008) -  EnerTeck Corporation (OTCBB: ETCK) (the
&quot;Company&quot;) announced today that, commencing December 15, 2008, its wholly
owned subsidiary, EnerTeck Chemical Corp. (&quot;ECC&quot;), working jointly with a
major American Class 1 railroad company, will initiate a performance
demonstration of the fuel savings, environmental and other benefits of the
utilization of its principal product, EnerBurn&reg;, for the railroad
industry.
]]></description>
		</item>
		<item>
			<title><![CDATA[DSM to sell Solutech to Lydall, Inc.]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=288781</link>
			<pubDate>Tue, 02 Dec 2008 02:23:00 EST</pubDate>
			<description><![CDATA[HEERLEN, NETHERLANDS--(eMediaWorld - December 2, 2008) - 

Royal DSM N.V., the global Life Sciences and Materials Sciences
company headquartered in the Netherlands, today announces that a
definitive agreement has been signed to sell its Solutech business to
Lydall, Inc., the United States-based specialty engineered products
manufacturer. Financial details of the transaction will not be
disclosed.

The DSM Solutech business, which primarily consists of two production
facilities in the Netherlands, contributed approximately EUR 3
million to DSM&#039;s total net sales in 2007. Lydall has been a
development partner for Solutech since 2007 and as part of the
agreement DSM will continue to cooperate with Lydall.
]]></description>
		</item>
		<item>
			<title><![CDATA[UCB announces start of Phase I study for antibody drug candidate CDP6038]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=288782</link>
			<pubDate>Tue, 02 Dec 2008 01:17:00 EST</pubDate>
			<description><![CDATA[BRUSSELS, BELGIUM--(eMediaWorld - December 2, 2008) - 

Brussels (Belgium), December 2, 2008 at 07:00 AM (CET) - UCB
announced today that its CDP6038 antibody drug candidate targeting
IL-6 has achieved a key milestone as the first subjects have been
dosed in its Phase 1 &#039;first in human&#039; study.

Interleukin-6 (IL-6) is one of several cytokines involved in the
inflammatory process. CDP6038 is thus part of UCB&#039;s long-term
commitment to the field of immunology and, in pre-clinical studies,
has already shown potential in a number of auto-immune diseases.
]]></description>
		</item>
		<item>
			<title><![CDATA[Potash One&#039;s First Resource Confirmation Well Intersects a Total of 39.6 Meters of Potash Mineralization With Average Grade of 18.3% K2O]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=288118</link>
			<pubDate>Mon, 01 Dec 2008 12:00:00 EST</pubDate>
			<description><![CDATA[VANCOUVER, BRITISH COLUMBIA--(eMediaWorld - Dec. 1, 2008) - Potash One Inc. (TSX:KCL) (the &quot;Company&quot; or &quot;Potash One&quot;) is pleased to announce that the company&#039;s first resource confirmation well of the 100% owned 97,240 acre Potash One Legacy Project, &#039;South-1&#039;, has intersected a total of 39.6 meters of potash mineralization with an average grade of 18.3% K2O. The potash intersection consists of three distinct potash mineralization zones. Geological correlation of the potash zones to Prairie Evaporite geological members is currently ongoing. All depths presented herein are from a vertical hole and as drilled. The following tables summarize select geostatistics of South-1.

]]></description>
		</item>
		<item>
			<title><![CDATA[Potash One&#039;s First Resource Confirmation Well Intersects a Total of 39.6 Meters of Potash Mineralization With an Average Grade of 18.3% K2O]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=287910</link>
			<pubDate>Mon, 01 Dec 2008 09:01:00 EST</pubDate>
			<description><![CDATA[VANCOUVER, BRITISH COLUMBIA--(eMediaWorld - Dec. 1, 2008) - Potash One Inc. (the &quot;Company&quot; or &quot;Potash One&quot;) (TSX:KCL) is pleased to announce that the company&#039;s first resource confirmation well of the 100% owned 97,240 acre Potash One Legacy Project, &#039;South-1&#039;, has intersected a total of 39.6 meters of potash mineralization with an average grade of 18.3% K2O. The potash intersection consists of three distinct potash mineralization zones. Geological correlation of the potash zones to Prairie Evaporite geological members is currently ongoing. All depths presented herein are from a vertical hole and as drilled. The following tables summarize select geostatistics of South-1.

]]></description>
		</item>
		<item>
			<title><![CDATA[Active Biotech&#039;s election committee appointed]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=286392</link>
			<pubDate>Fri, 28 Nov 2008 04:36:00 EST</pubDate>
			<description><![CDATA[LUND, SWEDEN--(eMediaWorld - November 28, 2008) -  In accordance with the decision by
the Annual General Meeting on May
7, 2008, the election committee shall consist of representatives
from
the three largest shareholders as at the end of October and the
Chairman of the Board.

The election committee for the next Board election consists of
Johnny
Sommarlund for MGA  Holding, Tomas Billing  for Nordstjernan and
Ulf
Str&ouml;msten for Catella funds.

Headed by  the  Chairman of  the  Board, Mats  Arnh&ouml;g,  the
election
committee will prepare a proposal for the composition of the Board
to
be presented to the Annual General Meeting on May 7, 2009.
]]></description>
		</item>
		<item>
			<title><![CDATA[DSM Opens Third Premix Plant in China to Support Further Growth]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=286393</link>
			<pubDate>Fri, 28 Nov 2008 02:29:00 EST</pubDate>
			<description><![CDATA[HEERLEN, NETHERLANDS--(eMediaWorld - November 28, 2008) - 

Royal DSM N.V., the global Life Sciences and Materials Sciences
company headquartered in the Netherlands, today announces that DSM
Nutritional Products has opened its third premix plant in China. The
new facility allows DSM to serve a larger geographical area in China.
This enables the company to capitalize on opportunities that arise
from the rapidly growing animal nutrition &amp; health industry in one of
the key growth countries for DSM.
]]></description>
		</item>
		<item>
			<title><![CDATA[Zealand Pharma and Helsinn Healthcare Sign a Partnering Agreement for ZP1846, a novel GLP-2 agonist]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=286394</link>
			<pubDate>Thu, 27 Nov 2008 04:41:00 EST</pubDate>
			<description><![CDATA[COPENHAGEN, DENMARK--(eMediaWorld - November 27, 2008) - 

Summary:

Zealand Pharma A/S and Helsinn Healthcare SA today announced that it
has signed a partnering agreement, for the development and worldwide
commercialization of ZP1846, a GLP-2 (glucagon-like peptide-2)
receptor agonist which provides a novel way to treat
chemotherapy-induced diarrhea (CID), a debilitating condition
affecting patients undergoing cancer treatment with a range of
chemotherapies.

Deal terms

Under the terms of the agreement, Helsinn Healthcare will receive a
worldwide exclusive license to ZP1846 and will be responsible for all
further development, regulatory approvals, manufacturing, marketing
and sales of the compound either on its own or through its
sub-licensees. In return Helsinn Healthcare will pay Zealand Pharma
development milestones and sales milestones for an undisclosed
amount. In addition, Zealand Pharma will receive royalties on future
sales and Zealand Pharma has retains the]]></description>
		</item>
		<item>
			<title><![CDATA[Pacific Sands Reports Fiscal 1Q 2009 Results]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=285610</link>
			<pubDate>Wed, 26 Nov 2008 13:00:00 EST</pubDate>
			<description><![CDATA[New Products Drive 96% Sales Increase; In-House Manufacturing Initiative Completed; New Retail and Corporate Websites Go Live; Natural Choices Private Label Branding Continues to Expand]]></description>
		</item>
		<item>
			<title><![CDATA[Agrium to Present at Upcoming Investor Conference]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=285611</link>
			<pubDate>Wed, 26 Nov 2008 07:30:00 EST</pubDate>
			<description><![CDATA[CALGARY, ALBERTA--(eMediaWorld - Nov. 26, 2008) - 

ALL AMOUNTS ARE STATED IN U.S.$

Agrium Inc. (TSX:AGU) (NYSE:AGU) announced today that Mike Wilson, President and Chief Executive Officer will be presenting at the 19th Annual Citi Chemicals Conference in New York on Wednesday, December 3, 2008 at 8:15 a.m. ET.

Agrium will host a live audio webcast of the investor presentations at www.agrium.com, which will be approximately 30 minutes in length. The presentations will be archived on Agrium&#039;s website.

]]></description>
		</item>
		<item>
			<title><![CDATA[Slowing House Construction Affects North American Vinyl Producers, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=285612</link>
			<pubDate>Wed, 26 Nov 2008 07:30:00 EST</pubDate>
			<description><![CDATA[SUGAR LAND, TX--(eMediaWorld - November 26, 2008) -  Researched by Industrial Info Resources
(Sugar Land, Texas) -- While one generally regards the slowing of the
housing-construction market as primarily affecting contractors and the
manufacturers of structural materials such as cement, the market is also
affecting the Chemical Processing Industry, particularly manufacturers of
vinyls, which are used in products such as vinyl siding, moldings, and PVC
piping.  One example of a company affected by the housing slowdown is
Georgia Gulf Corporation (NYSE:GGC) (Atlanta, Georgia), which gets about
two-thirds of its revenues from vinyls and aromatics, including acetone,
cumene and phenol.
]]></description>
		</item>
		<item>
			<title><![CDATA[North American Chemical Project Cancellations in November Approach $500 Million, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=285613</link>
			<pubDate>Wed, 26 Nov 2008 06:30:00 EST</pubDate>
			<description><![CDATA[SUGAR LAND, TX--(eMediaWorld - November 26, 2008) -  Researched by Industrial Info Resources
(Sugar Land, Texas) -- As part of Industrial Info&#039;s ongoing process of
updating and verifying active projects in the North American Chemical
Processing Industry (CPI), nearly 30 projects have been identified this
month as placed on hold or canceled entirely, representing a total
investment value of $500 million. 

For details, view the entire article by subscribing to Industrial Info&#039;s
Premium Industry News at
http://www.industrialinfo.com/showNews.jsp?newsitemID=141543, or browse
other breaking industrial news stories at www.industrialinfo.com.
]]></description>
		</item>
		<item>
			<title><![CDATA[FDA issues Complete Response Letter for ceftobiprole]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=285614</link>
			<pubDate>Wed, 26 Nov 2008 01:31:00 EST</pubDate>
			<description><![CDATA[BASEL, SWITZERLAND--(eMediaWorld - November 26, 2008) -  Basilea Pharmaceutica Ltd.
announces that the U.S. Food and Drug Administration (FDA) issued to
the sponsor, Johnson &amp; Johnson Pharmaceutical Research and
Development, L.L.C. (J&amp;JPRD), a Complete Response Letter for
ceftobiprole for the treatment of complicated skin and skin structure
infections including diabetic foot infections.

Ceftobiprole showed in two large multinational, double-blind,
randomized phase III clinical studies, that it was effective, as
demonstrated by meeting the primary endpoint using a 10%
non-inferiority margin. A safety profile consistent with the
cephalosporin class of antibiotics was demonstrated. Ceftobiprole has
been approved or recommended for approval in a number of territories
including the European Union.
]]></description>
		</item>
		<item>
			<title><![CDATA[GelTech Solutions Breaks Into Asian Marketplace With $3.2 Million Contract]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=284255</link>
			<pubDate>Tue, 25 Nov 2008 08:00:00 EST</pubDate>
			<description><![CDATA[Opening Order of $268,000]]></description>
		</item>
		<item>
			<title><![CDATA[DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=283917</link>
			<pubDate>Tue, 25 Nov 2008 01:53:00 EST</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS and PARSIPPANY, NJ--(eMediaWorld - November 25, 2008) - 

DSM Biologics, a business unit of DSM Pharmaceutical Products, and  Dutch
biotechnology company  Crucell N.V.  (Euronext, NASDAQ:  CRXL;  Swiss
Exchange: CRX),  today announced  that Hungary-based  Gedeon  Richter
Plc. signed a commercial license agreement allowing Gedeon Richter to
develop  and  produce  certain  biopharmaceuticals  on  the   PER.C6&reg;
platform. Other terms of the agreement were not disclosed.
]]></description>
		</item>
		<item>
			<title><![CDATA[Biovitrum&#039;s and Syntonix&#039;s Novel Factor IXFc for Hemophilia B has Received Orphan Drug Designation From the FDA]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=282736</link>
			<pubDate>Mon, 24 Nov 2008 08:01:00 EST</pubDate>
			<description><![CDATA[STOCKHOLM, SWEDEN--(eMediaWorld - November 24, 2008) - 

Stockholm, Sweden and Waltham, MA  - November 24, 2008. Biovitrum  AB
(publ) (STO: BVT) and Syntonix Pharmaceuticals, Inc., a subsidiary  of
Biogen Idec (NASDAQ: BIIB) today  announced that the company&#039;s  FIXFc
compound for the  control and prevention  of hemorrhagic episodes  in
patients with hemophilia  B has received  an orphan-drug  designation
from the US Food and Drug Administration (FDA). The FIXFc compound is
a recombinant protein in early-stage development for the treatment of
hemophilia  B,  a  hereditary  bleeding  disorder  characterized   by
impaired production  of  factor  IX  and  the  blood&#039;s  inability  to
coagulate. The Fc fusion  with factor IX is  intended to prolong  the
effect of the compound, the goal  being that patients will need  less
frequent prophylactic treatments  than currently existing  therapies,
which require two to four adm]]></description>
		</item>
		<item>
			<title><![CDATA[Newfield Exploration and Ecosphere Technologies Sign Water Recycling Services Agreement]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=282738</link>
			<pubDate>Mon, 24 Nov 2008 08:00:00 EST</pubDate>
			<description><![CDATA[Pilot Program Successfully Completed Ahead of Schedule]]></description>
		</item>
		<item>
			<title><![CDATA[BASF Joins List of Chemical Companies Planning Global Capacity Reductions, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=281681</link>
			<pubDate>Fri, 21 Nov 2008 08:00:00 EST</pubDate>
			<description><![CDATA[SUGAR LAND, TX--(eMediaWorld - November 21, 2008) -  Researched by Industrial Info Resources
(Sugar Land, Texas) -- The chemical industry is beginning to respond to a
slowing global economy that looks like it will remain slow well into next
year. BASF SE (OTC:BASFY) (Ludwigshafen, Germany) this week announced
intentions to temporarily close up to 80 plants around the world and reduce
production at many more. Industrial Info has identified over $1 billion of
planned grassroot construction by BASF, most of which is certain to be
delayed or postponed.
]]></description>
		</item>
		<item>
			<title><![CDATA[LaPolla Reports Third Quarter Profit]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=281219</link>
			<pubDate>Thu, 20 Nov 2008 17:46:00 EST</pubDate>
			<description><![CDATA[Foam Sales Soar 96% Despite Depressed Economic Conditions]]></description>
		</item>
		<item>
			<title><![CDATA[Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate in Fibromyalgia]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=281220</link>
			<pubDate>Thu, 20 Nov 2008 16:06:00 EST</pubDate>
			<description><![CDATA[BRUSSELS, BELGIUM--(eMediaWorld - November 20, 2008) - 

Preliminary Top Line Results of Phase III Trial Show Significant
Decreases in Pain and Fatigue and Improved Daily Function in
Fibromyalgia Patients

PALO ALTO, CA/USA and BRUSSELS, Belgium, November 20, 2008 at
10:00 PM (CET) - press release, regulated information - Jazz
Pharmaceuticals, Inc. (Nasdaq: JAZZ) and UCB (Euronext Brussels: UCB)
announced today positive preliminary top-line results from the first
of two Phase III clinical trials of sodium oxybate (JZP-6) for the
treatment of fibromyalgia. The randomized, double-blind,
placebo-controlled study achieved its key endpoints, demonstrating
that sodium oxybate significantly decreased pain and fatigue, and
improved daily function in patients with fibromyalgia.
]]></description>
		</item>
		<item>
			<title><![CDATA[Chemical Catalyst Producers Invest in Future Demand, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=280030</link>
			<pubDate>Thu, 20 Nov 2008 07:30:00 EST</pubDate>
			<description><![CDATA[SUGAR LAND, TX--(eMediaWorld - November 20, 2008) -  Researched by Industrial Info Resources
(Sugar Land, Texas) -- Investments by producers of chemical catalysts have
been strong during recent years, with current and ongoing investments
totaling more than $230 million. In addition to these projects, another
$160 million or more has been identified with plans to begin construction
during 2009. These catalysts serve a broad market including petroleum
refiners, chemical plastics and resins, pharmaceuticals and many other
industries. Most of these end markets have enjoyed strong demand in recent
years with a very favorable future outlook.
]]></description>
		</item>
		<item>
			<title><![CDATA[Biovitrum and Symphogen Report Positive Clinical Results in Novel Rh- immunization Prevention Project]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=280031</link>
			<pubDate>Thu, 20 Nov 2008 07:06:00 EST</pubDate>
			<description><![CDATA[STOCKHOLM, SWEDEN and COPENHAGEN, DENMARK--(eMediaWorld - November 20, 2008) -  Biovitrum AB
(publ)  (STO: BVT) and Symphogen  A/S have completed  the
first part of a clinical proof of mechanism study of the  recombinant
human polyclonal  antibody product  Sym001 for  future prevention  of
Hemolytic Disease of the Newborn (HDN) that can occur in RhD-negative
mothers carrying a  RhD-positive fetus.  This can lead  to an  immune
reaction causing destruction of the  red blood cells in the  newborn,
which may give rise to severe anemia, jaundice, and even cause  heart
failure and fatality.
]]></description>
		</item>
		<item>
			<title><![CDATA[CNOOC Begins Construction of 800,000-Ton Methanol Project in Hainan, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=280032</link>
			<pubDate>Thu, 20 Nov 2008 07:00:00 EST</pubDate>
			<description><![CDATA[BEIJING--(eMediaWorld - November 20, 2008) -  Researched by Industrial Info Resources (Sugar
Land, Texas) -- After three years of planning and preparations, China
National Offshore Oil Corporation (NYSE:CEO) (CNOOC) (Beijing) has begun
construction of a $147 million, 800,000-ton-per-year methanol project in
Dongfang Chemical City in Hainan province.

For details, view the entire article by subscribing to Industrial Info&#039;s
Premium Industry News at
http://www.industrialinfo.com/showNews.jsp?newsitemID=141392, or browse
other breaking industrial news stories at www.industrialinfo.com.
]]></description>
		</item>
		<item>
			<title><![CDATA[China Shuangji Cement Announces Third Quarter 2008 Results]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=279780</link>
			<pubDate>Wed, 19 Nov 2008 18:16:00 EST</pubDate>
			<description><![CDATA[ZHAOYUAN CITY, CHINA--(eMediaWorld - November 19, 2008) -  China Shuangji Cement Ltd. (OTCBB: CNSJ) (&quot;China Shuangji&quot; or the &quot;Company&quot;), a leading producer of high grade
cement in China, announced today reported results for the third quarter
ended on September 30, 2008.

Third Quarter 2008 highlights: Revenue totaled $13.2 million, down 10.5%
from the third quarter of 2007. Gross Profits totaled $1.90 million, down
18.5% from the third quarter of 2007. Operating Income totaled $1.44
million down 25% from the third quarter of 2007. Net Income before taxes
during the third quarter of 2008 was $1,148,779. Net Income during the
third quarter of 2008 was $761,400, or $0.03 per share. The Company
received a partial compensation of $5.11 million by the Chinese government
to relocate the Zhaoyuan cement plant. The Company also received an
additional concession of $7.45 million in loan forgiveness with one of
their banks. &quot;We a]]></description>
		</item>
		<item>
			<title><![CDATA[ABLYNX PROVIDES A BUSINESS UPDATE FOR THE THIRD QUARTER 2008]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=278064</link>
			<pubDate>Wed, 19 Nov 2008 12:41:00 EST</pubDate>
			<description><![CDATA[GHENT, BELGIUM--(eMediaWorld - November 19, 2008) - 

REGULATED INFORMATION

Ablynx [Euronext Brussels:  ABLX],
a pioneer in the  discovery and development  of Nanobodies&reg;, a
novel
class of antibody-derived  therapeutic proteins,  today provides
its
non-audited business update, in  compliance with the EU
transparency
directive,  summarising  material   events  and  Ablynx&#039;s
financial
position for the third quarter of  2008 and approved by the Board
of
Directors on 19 November 2008.
]]></description>
		</item>
		<item>
			<title><![CDATA[IDES &amp; Firehole Technologies Launch Search Engine for Composite Material Datasheets]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=278066</link>
			<pubDate>Wed, 19 Nov 2008 12:26:00 EST</pubDate>
			<description><![CDATA[LARAMIE, WY--(eMediaWorld - November 19, 2008) -  IDES Inc. (www.ides.com), home of The Plastics
Web&reg; and the fastest growing search destination for the plastics
industry, and Firehole Technologies Inc. (www.fireholetech.com), a
developer of innovative simulation technologies for composite materials and
structures, announced today that both companies have developed and launched
a searchable database of composite material
properties and datasheets called Prospector:Composites.  The online
tool is designed to help engineers quickly locate technical property
information about composite materials.
]]></description>
		</item>
		<item>
			<title><![CDATA[DSM to divest DSM Deretil in management buy-out]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=277368</link>
			<pubDate>Wed, 19 Nov 2008 02:20:00 EST</pubDate>
			<description><![CDATA[HEERLEN, NETHERLANDS--(eMediaWorld - November 19, 2008) - 

Royal DSM N.V., the global Life Sciences and Materials Sciences
company headquartered in the Netherlands, announces today that it has
reached an agreement with the management of DSM Deretil on a
management buy-out. DSM Deretil is a business unit of DSM
Anti-Infectives. Financial details will not be disclosed.

This divestment fits in the strategic review of DSM Anti-Infectives
as announced in June 2007. DSM believes the greatest value will be
generated through a partnering strategy combined with innovation
initiatives and restructuring measures. The review opened
possibilities for divestments of separate businesses, such as DSM
Deretil.
]]></description>
		</item>
		<item>
			<title><![CDATA[Greystone Logistics&#039; Go-To-Market Strategy Yields Results]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=275554</link>
			<pubDate>Tue, 18 Nov 2008 06:00:00 EST</pubDate>
			<description><![CDATA[TULSA, OK--(eMediaWorld - November 18, 2008) -  Greystone Logistics, Inc. (OTCBB: GLGI) --
Greystone Logistics today announced numerous purchase orders resulting from
the Company&#039;s newly implemented Go-To-Market strategy. Previously the
company had indicated a move to more direct corporate sales, developing
closer ties with a larger number of professional materials handling groups,
and further expansion of the company&#039;s product line.
]]></description>
		</item>
		<item>
			<title><![CDATA[Infinity Alliance Ventures Inc. Announces Name Change to CBM Asia Development Corp.]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=274121</link>
			<pubDate>Mon, 17 Nov 2008 20:08:00 EST</pubDate>
			<description><![CDATA[VANCOUVER, BRITISH COLUMBIA--(eMediaWorld - Nov. 17, 2008) - Infinity Alliance Ventures Inc. (the &quot;Company&quot;) (TSX VENTURE:TCF)(FRANKFURT:IY2) is pleased to announce that it has received regulatory approval to change its name to CBM Asia Development Corp. effective November 18, 2008. The Company will continue trading on the TSX Venture Exchange under the symbol TCF.

The Company acquired its wholly-owned operating subsidiary, CBM Asia Development Corp., on August 12, 2008 and continues CBM Asia&#039;s exploration activities in Indonesia. Management feels it is in the best interest of the Company to change its name in order to reflect the nature of its business, as its wholly-owned operating subsidiary has been conducting business under the name CBM Asia Development Corp. since August 2006 and has a well established reputation in the Indonesian coalbed methane community.

]]></description>
		</item>
		<item>
			<title><![CDATA[Active Biotech AB Interim Report January-September 2008]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=269998</link>
			<pubDate>Fri, 14 Nov 2008 02:30:00 EST</pubDate>
			<description><![CDATA[LUND, SWEDEN--(eMediaWorld - November 14, 2008) - 


- Laquinimod -- positive data presented from extension study

- 57-57 -- Clinical Phase II/III trial to commence in 2009

- RhuDex&reg; -- Additional preclinical tests under way

- ANYARA -- Phase III study proceeding as planned

- TASQ -- Phase II study proceeding as planned

- Net sales SEK 8.8 M (8.7)

- Operating loss SEK 167.0 M (loss: 147.8 )

- Loss after tax SEK 162.0 M (loss: 152.0)

- Loss per share for the period amounted to SEK 3.30 (loss: 3.30)


For further information, please contact:
Tomas Leanderson
President and CEO
Tel: +46 (0)46-19 20 95

G&ouml;ran Forsberg
VP Investor Relations &amp; Business Development
Tel: +46 (0)46-19 11 54

Hans Kolam
CFO
Tel: +46 (0)46-19 20 44

Active Biotech AB
(Corp. Reg. No. 556223-9227)
PO Box 724, SE-220 07 Lund
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 11 00

]]></description>
		</item>
		<item>
			<title><![CDATA[Devgen concludes successful sales season and sets a solid base for substantial growth in 2009.]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=269999</link>
			<pubDate>Fri, 14 Nov 2008 01:06:00 EST</pubDate>
			<description><![CDATA[GENT-ZWIJNAARDE, BELGIUM--(eMediaWorld - November 14, 2008) - 

Webcast and conference call on Friday 14 November 2007 at 12.00  am.
A  link  is  available  on  Devgen&#039;s  home  page  www.devgen.com  and
participation in the conference call  is possible via the number  +32
(0)2 290 14 07.


Zwijnaarde, November 14, 2008. Devgen NV (Euronext Brussels: DEVG), a
public agricultural biotech  and seed company,  today reports on  the
successful conclusion  of its  first  full sales  season and  on  the
establishment of  a  solid base  for  growth  in India  in  2009.  In
addition Devgen reports on its entry with rice into Indonesia and the
Philippines.
]]></description>
		</item>
		<item>
			<title><![CDATA[AMNE to Change Transfer Agents and Issue Special Dividend]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=266824</link>
			<pubDate>Thu, 13 Nov 2008 06:30:00 EST</pubDate>
			<description><![CDATA[NEW HAVEN, CT--(eMediaWorld - November 13, 2008) -  American Green Group, Inc. (PINKSHEETS: AMNE)
decided it is in the best interests of its shareholders to change Transfer
Agents and is in the process of setting up its new transfer agent Fidelity
Stock Transfer located in Utah.  AMNE will update the information on Pink
Sheets under its company info page.

AMNE will be creating a special class of Preferred stock that will be
issued to all shareholders of record as of a soon to be announced record
date.  The Preferred shares can be converted into common stock after One
year at the rate of Five Common shares for every One Preferred redeemed.
AMNE is planning on issuing One Preferred for every 20 shares of Common
owned as of the soon to be announced record date.
]]></description>
		</item>
		<item>
			<title><![CDATA[Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives approval by Swissmedic]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=266826</link>
			<pubDate>Thu, 13 Nov 2008 01:25:00 EST</pubDate>
			<description><![CDATA[BASEL, SWITZERLAND--(eMediaWorld - November 13, 2008) -  Basilea Pharmaceutica Ltd.
announces that ceftobiprole (ZevteraT), the first-in-class
anti-MRSA broad-spectrum cephalosporin, has obtained regulatory
approval from Swissmedic for the treatment of complicated skin and
soft tissue infections including diabetic foot infections.

Dr. Anthony Man, CEO of Basilea said, &quot;We are delighted by this
approval of ceftobiprole by Swissmedic. This is an important moment
for our company and brings a novel and effective treatment against
resistant bacteria to patients and physicians here in Switzerland.&quot;
]]></description>
		</item>
		<item>
			<title><![CDATA[Biovitrum Extends ReFacto(R) Supply Agreement with Wyeth until December 31, 2015]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=264635</link>
			<pubDate>Wed, 12 Nov 2008 02:38:00 EST</pubDate>
			<description><![CDATA[STOCKHOLM, SWEDEN--(eMediaWorld - November 12, 2008) - 

STOCKHOLM, Sweden and MADISON, New  Jersey, USA - November 12,  2008.
Biovitrum AB (publ) (STO: BVT) and Wyeth (NYSE: WYE) today announced an
extension of the ReFacto&reg; supply  agreement until December 31,  2015.
Biovitrum will continue to be the sole producer of drug substance for
Wyeth for ReFacto&reg;,  as well  as Xyntha&reg;/ReFacto&reg;  AF, the  successor
products, and will continue to receive royalties from Wyeth&#039;s  global
sales. Biovitrum&#039;s co-promotion  rights in the  Nordic region  remain
unchanged.
]]></description>
		</item>
		<item>
			<title><![CDATA[OctoPlus wins new drug delivery evaluation contract]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=264636</link>
			<pubDate>Wed, 12 Nov 2008 02:16:00 EST</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - November 12, 2008) - 

As part  of  the  Company&#039;s recently  announced  strategic  focus  on
developing controlled release formulations for clients, OctoPlus N.V.
(&quot;OctoPlus&quot; or &quot;the Company&quot;)  (Euronext: OCTO) announces today  that
it has signed a new drug delivery technology evaluation contract with
a US-based biotech company.

On 6 October OctoPlus announced a licensing agreement with Biolex
Therapeutics, to license Locteron&reg;, a product based on OctoPlus&#039;
PolyActive&reg; drug delivery technology, to Biolex. OctoPlus&#039; strategy
will increasingly focus on developing controlled release versions of
existing or new drugs for clients, in addition to providing general
formulation development and clinical material manufacturing.
Currently, OctoPlus is working on five projects to develop a
controlled release formulation for a client.
]]></description>
		</item>
		<item>
			<title><![CDATA[Huntsman Posts $20.2 Million Loss for 3Q; Continues Pursuit to See Hexion Merger Completed This Year, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=263091</link>
			<pubDate>Tue, 11 Nov 2008 07:30:00 EST</pubDate>
			<description><![CDATA[SUGAR LAND, TX--(eMediaWorld - November 11, 2008) -  Researched by Industrial Info Resources
(Sugar Land, Texas) -- Huntsman Corporation (NYSE:HUN) (The Woodlands,
Texas), a leading global manufacturer of chemicals, has posted a
third-quarter net loss of $20.2 million, compared with a net loss of $150
million in the same period last year. Capital expenditures totaled $101
million in the quarter, and the company plans to spend between $440 million
and $450 million this year, said J. Kimo Esplin, Executive Vice President
and Chief Financial Officer. As part of our North American Project Database, Industrial Info is currently
tracking active Huntsman project activity exceeding $250 million with
projects ranging in size from $5 million to more than $100 million.
]]></description>
		</item>
		<item>
			<title><![CDATA[Poly-Pacific Signs Gasification License Agreement for China]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=259928</link>
			<pubDate>Mon, 10 Nov 2008 08:30:00 EST</pubDate>
			<description><![CDATA[EDMONTON, ALBERTA--(eMediaWorld - Nov. 10, 2008) - Poly-Pacific International Inc. (&quot;Poly-Pacific&quot; or the &quot;Company&quot;) (TSX VENTURE:PMB)(OTCBB:PLYPF)(BERLIN:A0LGDN)(FRANKFURT:POZ) is pleased to announce that it has signed a License Agreement with Energy Quest Inc. (OTCBB:EQST). Under the terms of this agreement, the Company will have the exclusive rights to commercialize and/or or manufacture, market and distribute Energy Quest&#039;s Gasification Technologies in the People&#039;s Republic of China, which includes Mainland China, Hong Kong and Macau.

]]></description>
		</item>
		<item>
			<title><![CDATA[Ecosphere Technologies Delivers Mobile Water Recycling Plant to Newfield Exploration in Oklahoma]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=259930</link>
			<pubDate>Mon, 10 Nov 2008 08:00:00 EST</pubDate>
			<description><![CDATA[STUART, FL--(eMediaWorld - November 10, 2008) -  Ecosphere Technologies, Inc. (OTCBB: ESPH), a
diversified water engineering and services company, announces today the
delivery of one of its Ecosphere Ozonix mobile water recycling systems to
Newfield Exploration Company&#039;s mid-continent operations near Coalgate,
Oklahoma. The Ozonix mobile water recycling system is a fully self
contained water recycling plant on a 53&#039; mobile trailer that can be moved
from well site to well site to process frac flowback water.
]]></description>
		</item>
		<item>
			<title><![CDATA[Toba Industries Ltd. Announces Completion of the $1,283,002 Million Financing and Reverse Takeover of Beijing Marvel]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=259107</link>
			<pubDate>Fri, 07 Nov 2008 23:15:00 EST</pubDate>
			<description><![CDATA[VANCOUVER, BRITISH COLUMBIA--(eMediaWorld - Nov. 7, 2008) - Toba Industries Ltd. (NEX:TBG.H) (the &quot;Company&quot; or &quot;Toba&quot;) is pleased to announce the completion of the $1,283,002 financing and reverse takeover of Beijing Marvel Cleansing Supplies Co. Ltd. (&quot;Beijing Marvel&quot;), formerly known as Peking Marvel Cleansing Supplies Co., Ltd. Beijing Marvel is a leading wet wipes manufacturer in China that produces a variety of nonwoven wipe products for personal and household applications. All of the conditions submitted to the TSX Venture Exchange in the press release dated October 1, 2007 have been met. The Company&#039;s name will officially change to Beijing Marvel Cleaning Supplies Co. Ltd., and will trade under the new symbol &quot;BMW&quot; on the TSX Venture Exchange.

]]></description>
		</item>
		<item>
			<title><![CDATA[Canexus Announces November Distribution]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=257454</link>
			<pubDate>Fri, 07 Nov 2008 10:48:00 EST</pubDate>
			<description><![CDATA[CALGARY, ALBERTA--(eMediaWorld - Nov. 7, 2008) - Canexus Income Fund (TSX:CUS.UN) (the &quot;Fund&quot;) today announced the cash distribution for the period November 1, 2008, to November 30, 2008, has been set at $0.0456 per unit. The distribution will be paid on December 15, 2008, to unitholders of record as at November 28, 2008. This payment is consistent with the Fund&#039;s distribution policy.

The Fund has a Distribution Reinvestment Plan (&quot;DRIP&quot;) that enables participants to automatically reinvest monthly distributions in additional trust units of the Fund. More information on the DRIP is available on the Canexus website at www.canexus.ca.

]]></description>
		</item>
		<item>
			<title><![CDATA[Ecosphere Technologies Announces $2 Million Investment From Bledsoe Capital Group]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=257456</link>
			<pubDate>Fri, 07 Nov 2008 08:00:00 EST</pubDate>
			<description><![CDATA[Investment Signals Bledsoe Capital Group&#039;s Continued Commitment to Ecosphere&#039;s Ozonix Technology]]></description>
		</item>
		<item>
			<title><![CDATA[IBM Signs Agreement With Japan Industrial Waste Technology Center to Upgrade Registration and Management System]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=256390</link>
			<pubDate>Thu, 06 Nov 2008 14:05:00 EST</pubDate>
			<description><![CDATA[TOKYO--(eMediaWorld - November 6, 2008) -  IBM (NYSE: IBM) today announced an agreement with the
Japan Industrial Waste Technology Center to upgrade its &quot;JWNET&quot; electronic
manifest system for industrial waste. The electronic manifest system is a
digital system that can manage the entire flow of online information
exchanges on industrial waste to final processing between dischargers,
collectors and transferors, and disposal contractors. The upgraded system
will be launched in May 2010 and should provide a reliable and flexible
infrastructure to correspond with the increasing number of registrations
and transactions. The agreement was signed in October 2008.
]]></description>
		</item>
		<item>
			<title><![CDATA[SAFER Systems Launches Major New Release of Its SAFER Real-Time(R) Chemical Emergency Management System]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=256391</link>
			<pubDate>Thu, 06 Nov 2008 12:32:00 EST</pubDate>
			<description><![CDATA[CAMARILLO, CA--(eMediaWorld - November 6, 2008) -  SAFER Systems, the global technology leader
in chemical emergency management solutions, today announced that it has
released the latest version of SAFER Real-Time, the company&#039;s highly
integrated, comprehensive system for detecting, analyzing and responding to
toxic chemical release emergencies. SAFER Real-Time
Version 10 uniquely equips its users with a range of vital information
that enables better emergency planning, decision-making and response.
]]></description>
		</item>
		<item>
			<title><![CDATA[Shareholders meeting OctoPlus approves new Executive Board and Supervisory Directors]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=256393</link>
			<pubDate>Thu, 06 Nov 2008 11:56:00 EST</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - November 6, 2008) - 

OctoPlus N.V.  (&quot;OctoPlus&quot; or  &quot;the Company&quot;)  (Euronext: OCTO),  the
drug delivery  company,  announces  today  that  its  Annual  General
Meeting  of  Shareholders  (the  &quot;Meeting&quot;)  has  appointed  the  new
Executive Board  and  adopted a  change  in the  composition  of  the
Supervisory Board of Directors.

On 16  October,  OctoPlus announced  that  the Board  of  Supervisory
Directors proposed  to  expand  the  Executive  Board  with  two  new
members. The  new Board  would consist  of Chief  Executive  Officer,
Simon Sturge, Joost Holthuis, current CEO and founder, who would take
up the  new  position of  Chief  Operating Officer,  Chief  Financial
Officer Hans Pauli and Chief Business Officer Gerben Moolhuizen.
]]></description>
		</item>
		<item>
			<title><![CDATA[Active Biotech to Present at the Rodman &amp; Renshaw 10th Annual Healthcare Conference]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=254885</link>
			<pubDate>Thu, 06 Nov 2008 02:30:00 EST</pubDate>
			<description><![CDATA[LUND, SWEDEN--(eMediaWorld - November 6, 2008) -  Lund, Sweden, November 6, 2008 - Active
Biotech (NASDAQ OMX Nordic:
ACTI) is scheduled to present at the Rodman &amp; Renshaw 10th Annual
Healthcare Conference on Tuesday, November 11 at the New York Palace
Hotel in New York City, US. During the presentation, an update
regarding Active Biotech&#039;s development programs will be provided.


The presentation will include the Phase III projects laquinimod, a
novel oral immunomodulatory drug for the treatment of multiple
sclerosis, which is licensed to Teva Pharmaceutical Industries Ltd
and ANYARA, Active Biotech&#039;s novel concept for tumor therapy in a
Phase III study for renal cell cancer. Also, data from the prostate
cancer project TASQ will be presented and an update on the SLE
project 57-57 as well as the new project around the mode of action of
the quinoline technology.
]]></description>
		</item>
		<item>
			<title><![CDATA[QIAGEN and Institute for Animal Health Enter Partnership in Bluetongue Testing]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=254886</link>
			<pubDate>Thu, 06 Nov 2008 02:07:00 EST</pubDate>
			<description><![CDATA[KJ VENLO, GERMANY--(eMediaWorld - November 6, 2008) - 

 Worldwide license agreement expands the Company&#039;s veterinary assay
  portfolio and aims to contain future outbreaks of the devastating
                            viral disease

Venlo, The  Netherlands -  November 6,  2008 -  QIAGEN N.V.  (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) has announced today that it  has
entered into a worldwide exclusive partnership with the Institute for
Animal Health (IAH), a  leading research and diagnostics  institution
for infectious diseases  of farm animals.  Pursuant to the  agreement
QIAGEN has licensed a novel molecular assay design for bluetongue,  a
devastating viral disease among ruminants  such as sheep and  cattle.
The cador BTV  RT-PCR Kit, which  was developed by  the IAH, will  be
launched  by  QIAGEN  in  2009  and  further  expand  the   company&#039;s
veterinary testing portfolio.
]]></description>
		</item>
		<item>
			<title><![CDATA[Congoleum Corporation Reports Third Quarter Results]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=254887</link>
			<pubDate>Wed, 05 Nov 2008 17:01:00 EST</pubDate>
			<description><![CDATA[MERCERVILLE, NJ--(eMediaWorld - November 5, 2008) -  Congoleum Corporation (PINKSHEETS: CGMC)
today reported its financial results for the third quarter ended September
30, 2008.  Sales for the three months ended September 30, 2008 were $46.1
million, compared with sales of $53.6 million reported in the third quarter
of 2007, a decrease of 14%.  During the third quarter, based upon the
progress in its Chapter 11 proceedings and the estimated cost to complete
its reorganization in the second quarter of 2009, Congoleum recorded a
charge of $11.5 million to increase its reserve for asbestos related costs.
The net loss for the quarter, which includes the charge of $11.5 million
for asbestos related reorganization costs, was $10.1 million, compared with
net income of $1.2 million in the third quarter of 2007. Net loss per share
was $1.22 in the third quarter of 2008 compared with net income of $.15 per
share in the third ]]></description>
		</item>
		<item>
			<title><![CDATA[Potash One Working Capital Increases to $27 Million With Closing of $10.375 Million Flow Through Financing]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=249282</link>
			<pubDate>Mon, 03 Nov 2008 13:15:00 EST</pubDate>
			<description><![CDATA[VANCOUVER, BRITISH COLUMBIA--(eMediaWorld - Nov. 3, 2008) - Potash One Inc. (&quot;Potash One&quot; or the &quot;Corporation&quot;) (TSX:KCL) is pleased to announce that it has completed an oversubscribed, non-brokered private placement of flow-through shares of 8,300,000 at $1.25 per share (&quot;FT Share&quot;) for net proceeds of $10,375,000 (the &quot;Placement&quot;), as previously reported on October 22, 2008. The Corporation paid to certain finders cash fees aggregating $310,000 and 248,000 finders&#039; warrants for introducing the subscribers to the Corporation. Each finder&#039;s warrant will entitle the holder to purchase one non-flow-through common share at a price of $1.50 until October 30, 2009.

]]></description>
		</item>
		<item>
			<title><![CDATA[YASH Technologies Recognized as Development Partner of SAP(R) Chemical Best Practices]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=249283</link>
			<pubDate>Mon, 03 Nov 2008 09:00:00 EST</pubDate>
			<description><![CDATA[As a Contributing Development and Testing Partner, YASH Helps Build Best Practices for Release in India]]></description>
		</item>
		<item>
			<title><![CDATA[Koppers Refinances Bank Agreement]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=249284</link>
			<pubDate>Mon, 03 Nov 2008 08:32:00 EST</pubDate>
			<description><![CDATA[PITTSBURGH, PA--(eMediaWorld - November 3, 2008) -  Koppers Inc., a subsidiary of Koppers
Holdings Inc. (NYSE: KOP), has entered into a new credit agreement with a
syndicate of banks led by Pittsburgh-based PNC and co-led by RBS Citizens
Bank and Bank of America as joint book runners.  The four-year agreement
provides for a revolving credit facility of $300 million at an initial
interest rate of LIBOR plus 250 basis points, and is subject to certain
covenants including maximum leverage and minimum fixed charges coverage.
The agreement replaces the existing $125 million revolver and term loan
bank facilities that were to expire in late 2009.   After the closing of
the Monessen sale on October 1, 2008, there were no balances outstanding
under these facilities.
]]></description>
		</item>
		<item>
			<title><![CDATA[UCB on track]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=245588</link>
			<pubDate>Fri, 31 Oct 2008 01:01:00 EDT</pubDate>
			<description><![CDATA[BRUSSELS, BELGIUM--(eMediaWorld - October 31, 2008) - 


  * UCB on track to achieve 2008 and 2009 financial outlook
  * Three new drug launches in nine months
  * Continued roll-out of strategy
  * Early research with two new external partnerships


Brussels, Belgium, October 31, 2008 at 7:00 AM (CET) - press release,
regulated information - UCB announced today that the financial
performance of the UCB Group in the first nine months of 2008 was
in-line with the company&#039;s financial outlook 2008.
]]></description>
		</item>
		<item>
			<title><![CDATA[Pacific Sands Launches New Corporate and Brand Websites]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=240993</link>
			<pubDate>Wed, 29 Oct 2008 08:01:00 EDT</pubDate>
			<description><![CDATA[RACINE, WI--(eMediaWorld - October 29, 2008) -  Pacific Sands, Inc. (OTCBB: PFSD), developer and
manufacturer of the Natural Choices? brand of cleaning and laundry
products, as well as the simple, safe, effective and environmentally
friendlier ecoone&reg; chlorine-free pool and &#039;low chemical&#039; spa water
management solutions, announced today that the company has launched its
redesigned corporate website at www.pacificsands.biz.
]]></description>
		</item>
		<item>
			<title><![CDATA[Olin Posts $37.7 Million Profit From Strong Chlor-Alkali Performance Despite Hurricane Disruptions, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=240995</link>
			<pubDate>Wed, 29 Oct 2008 04:30:00 EDT</pubDate>
			<description><![CDATA[SUGAR LAND, TX--(eMediaWorld - October 29, 2008) -  Researched by Industrial Info Resources
(Sugar Land, Texas) -- The Olin Corporation (NYSE:OLN) (Clayton, Missouri)
has announced third-quarter 2008 earnings of $37.7 million, up from a
deficit of $83.2 million in the same period last year. The company also
posted a record operating income of $87 million in the quarter, up 130%
from last year&#039;s $37.8 million. Joseph Rupp, Chairman, President and CEO,
said the gains are largely attributable to strong performance in the
company&#039;s Chlor Alkali Products and Winchester businesses, as well as
continued benefits from the acquisition of Pioneer Companies Incorporated
(Houston, Texas), a manufacturer of chlorine, caustic soda, bleach,
hydrochloric acid and other related products. Industrial Info is tracking
10 active projects worth $162.9 million involving Olin, including a $146
million expansion of the St. Gabriel chlor-alkali plant in Louisiana.
]]></description>
		</item>
		<item>
			<title><![CDATA[DSM scientist selected for Joseph J. Mattiello Lecture 2009]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=240996</link>
			<pubDate>Wed, 29 Oct 2008 04:16:00 EDT</pubDate>
			<description><![CDATA[HEERLEN, NETHERLANDS--(eMediaWorld - October 29, 2008) - 

Royal DSM N.V., the global Life Sciences and Materials Sciences
company headquartered in the Netherlands, announces today that Ad
Overbeek, Global Science Manager DSM NeoResins+, has been selected by
The Federation of Societies for Coatings Technology (FSCT) to deliver
the 2009 Joseph J. Mattiello Memorial Lecture.

The award, considered by many to be the most prestigious in the
international coatings scientific community, recognizes individuals
who have made an outstanding contribution to the field of coatings
science and technology. The lecture forms the focal point of the
Mattiello Symposium and will be held on Tuesday 28 April 2009 during
the FSCT&#039;s CoatingsTech Conference in Indianapolis, Indiana (United
States).
]]></description>
		</item>
		<item>
			<title><![CDATA[Sony Selects VCT as FeliCa Card Supplier in North America]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=239068</link>
			<pubDate>Tue, 28 Oct 2008 16:35:00 EDT</pubDate>
			<description><![CDATA[DOWNERS GROVE, IL--(eMediaWorld - October 28, 2008) -  Versatile Card Technology, Inc. (VCT), a
world leader in card manufacturing, today announced that they have signed
an agreement with Sony Corporation, making them the North American
manufacturer for FeliCa contactless cards based on the ISO 18092 standard
(NFC).

     For VCT&#039;s part, the agreement represents a unique opportunity to
expand its product line with a new -- but already proven technology.
According to Rome Jett&eacute;, VCT&#039;s Vice President of Smart Cards, &quot;FeliCa
represents a major improvement in the flexibility, speed, and security of
transactions with respect to the traditional ISO 14443 based card
technologies now available in the US. With over 350 million FeliCa cards
and cell phones already deployed in some of the most demanding
applications, Sony has clearly proven that FeliCa technology is more than
ready for the American market.&quot;
]]></description>
		</item>
		<item>
			<title><![CDATA[Willbros Announces Third Quarter 2008 Earnings Release and Conference Call Schedule]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=239070</link>
			<pubDate>Tue, 28 Oct 2008 15:05:00 EDT</pubDate>
			<description><![CDATA[HOUSTON, TX--(eMediaWorld - October 28, 2008) -  Willbros Group, Inc. (NYSE: WG) today announced
plans to release third quarter 2008 results on Wednesday, November 5, 2008,
after the market closes.  In conjunction with the release, Willbros has
scheduled a conference call, which will be broadcast live over the Internet
on Thursday, November 6, 2008, at 9:00 a.m. Eastern Time (8:00 a.m.
Central).


     What:      Willbros Group, Inc. Third Quarter 2008 Earnings Conference
                Call
     When:      Thursday, November 6, 2008 ? 9:00 a.m. Eastern Time
     Where:     Live via phone by dialing 866-550-6338 or 347-284-6930,
                passcode 2684010, and asking for the Willbros call at least
                10 minutes prior to the start time.
     Where:     Live over the Internet by logging onto www.willbros.com on
                the home page under Events.
]]></description>
		</item>
		<item>
			<title><![CDATA[Dixon, Perot and Champion Inc. Finalizing Negotiations for Strategic Partnership for Mining Operations in Argentina]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=239072</link>
			<pubDate>Tue, 28 Oct 2008 09:44:00 EDT</pubDate>
			<description><![CDATA[NEW YORK, NY--(eMediaWorld - October 28, 2008) -  Dixon, Perot and Champion Inc.-(PINKSHEETS: DXPCF) is concluding negotiations to develop a strategic partnership with a
mining and exploration company in Argentina. The alliance would then
proceed to acquire mining properties in Argentina and potentially China.
Dixon, Perot and Champion intend to provide a large capital injection
towards the ongoing drilling operations in these countries. The current
economic market instability has motivated DXPCF to diversify their business
portfolio in the precious metal sectors and other stable markets. These
hard assets have historically maintained trade interest in unstable markets
that we are experiencing today. We strongly believe this partnership will
come to fruition in the next few months and the company will then begin
executing its exploration acquisitions in tactical locations in Argentina
and China.
]]></description>
		</item>
		<item>
			<title><![CDATA[Canexus Acquires Currency Option Protection for 2009]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=239073</link>
			<pubDate>Tue, 28 Oct 2008 09:02:00 EDT</pubDate>
			<description><![CDATA[CALGARY, ALBERTA--(eMediaWorld - Oct. 28, 2008) - Canexus Income Fund (TSX:CUS.UN) (the &quot;Fund&quot;) today announced that Canexus Limited Partnership (Canexus LP) has secured Canadian dollar foreign exchange call option contracts on US$10.0 million per month which entitle Canexus LP to sell US dollars and acquire Canadian dollars at an average price of US$0.8185 per Canadian dollar from January 1, 2009, through December 31, 2009.

&quot;We have capitalized on the tremendous opportunity presented by the significant devaluation of the Canadian dollar in the past few days. We now have foreign exchange rate certainty on virtually all of our net US dollar cash flow for next year if the Canadian dollar strengthens above US$0.8185 per Canadian dollar, while still allowing our cash flow to benefit from any devaluation of the Canadian dollar below this level,&quot; said Gary Kubera, President and CEO. &quot;This foreign currency protection should improve our cash flow by in excess of $30 million for 2009 versus d]]></description>
		</item>
		<item>
			<title><![CDATA[Active Biotech Presents New Data regarding the 57-57 SLE Project at American College of Rheumatology Meeting]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=239074</link>
			<pubDate>Tue, 28 Oct 2008 08:51:00 EDT</pubDate>
			<description><![CDATA[LUND, SWEDEN--(eMediaWorld - October 28, 2008) -  Active Biotech (NASDAQ OMX Nordic:
ACTI) has presented data regarding
the 57-57 project at the American College of Rheumatology (ACR)
Annual Scientific Meeting, a premier event for specialists in the
field of rheumatology, held in San Francisco October 24-29*.


In a completed Phase Ib trial twelve patients have been treated
for
84 days at various dose levels of ABR-215757. The maximum
tolerable
dose (MTD) for ABR-215757 was defined as 4.5 mg/day. The overall
safety profile throughout the study was very favorable.
]]></description>
		</item>
		<item>
			<title><![CDATA[Active Biotech Presents New Data regarding the 57-57 SLE Project at American College of Rheumatology Meeting]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=239076</link>
			<pubDate>Tue, 28 Oct 2008 08:33:00 EDT</pubDate>
			<description><![CDATA[LUND, SWEDEN--(eMediaWorld - October 28, 2008) -  Active Biotech (NASDAQ OMX Nordic:
ACTI) has presented data regarding
the 57-57 project at the American College of Rheumatology (ACR)
Annual Scientific Meeting, a premier event for specialists in the
field of rheumatology, held in San Francisco October 24-29*.


In a completed Phase Ib trial twelve patients have been treated
for
84 days at various dose levels of ABR-215757. The maximum
tolerable
dose (MTD) for ABR-215757 was defined as 4.5 mg/day. The overall
safety profile throughout the study was very favorable.
]]></description>
		</item>
		<item>
			<title><![CDATA[Leisure Direct, Inc. Changes Name, Has New Symbol, Starts New Subsidiaries, Increases Authorized Shares]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=239077</link>
			<pubDate>Tue, 28 Oct 2008 08:25:00 EDT</pubDate>
			<description><![CDATA[PERRYSBURG, OH--(eMediaWorld - October 28, 2008) -   LD Holdings, Inc., formerly Leisure Direct,
Inc., (OTCBB: LDHL) announced today that it has gone through a corporate
name change to reflect its new strategic direction towards providing
financial services and focusing on acquisitions without regard to any
specific industry.

Through its wholly owned subsidiary, LD Financial, Inc., the company has
started providing consulting services to corporate clients through its
Business Services Division.  This Division of LD Financial will initially
target a tri-state area consisting of Ohio, Indiana and Michigan and has
started generating revenue.   Plans are to establish additional regional
offices in the first half of 2009.
]]></description>
		</item>
		<item>
			<title><![CDATA[GelTech Solutions Secures Purchase Orders in Excess of $890,000 for Its Proprietary FireIce Product]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=239079</link>
			<pubDate>Tue, 28 Oct 2008 07:00:00 EDT</pubDate>
			<description><![CDATA[JUPITER, FL--(eMediaWorld - October 28, 2008) -  GelTech Solutions, Inc. (OTCBB: GLTC) announces
today that it has received six purchase orders totaling $896,500 for the
innovative fire suppressant FireIce&reg;.  The orders were received from an
operation geared to handle the very specific needs of the west coast fire
departments. This opening order includes six staggered purchase orders over
rolling two week periods with the 1st delivery date on 12/11/2008 giving
GelTech ample time to ramp up production.
]]></description>
		</item>
		<item>
			<title><![CDATA[DSM reports strong Q3 against deteriorating market conditions]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=235769</link>
			<pubDate>Mon, 27 Oct 2008 01:27:00 EDT</pubDate>
			<description><![CDATA[HEERLEN, NETHERLANDS--(eMediaWorld - October 27, 2008) - 


*       Continued strong organic sales growth (12%), driven by
  pricing power.
*       Sustained strong profitability in Nutrition.
*       Accelerating economic downturn increasingly visible in
  Materials Sciences.
*       EBIT from continuing operations up 27% to EUR 267 million;
  EPS up 41%.
*       2008 operating profit expected to be around EUR 1,000
  million.


Commenting on the results, Feike Sijbesma, chairman of the DSM
Managing Board, said: &quot;DSM has reported a strong third quarter result
and the company remains on track to achieve a record operating profit
in 2008. Nutrition profitability remains strong. DSM Agro benefited
from favorable market conditions. DSM&#039;s Materials Sciences businesses
also performed relatively well during Q3 but are facing more impact
from the deteriorating economic conditions in the last few weeks,
from which of course nobody is immune.
]]></description>
		</item>
		<item>
			<title><![CDATA[Basilea presents research data at ICAAC/IDSA on novel antibiotic addressing the emerging threat from multi-resistant Gram-negative bacteria]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=235771</link>
			<pubDate>Mon, 27 Oct 2008 01:15:00 EDT</pubDate>
			<description><![CDATA[BASEL, SWITZERLAND--(eMediaWorld - October 27, 2008) - 

Basel, Switzerland, October 27, 2008 - Multi-resistant Gram-negative
bacteria are causing increasing concern around the world. Basilea&#039;s
novel antibiotic BAL30072 demonstrates potent in-vitro activity
against some of the most difficult to treat multi-resistant
Gram-negative bacteria.

Basilea Pharmaceutica&#039;s Head of Biology, Prof. Malcolm Page,
presented in vitro data on Basilea&#039;s novel antibiotic BAL30072 at the
Poster Review Session of the joint meeting of the Annual Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the
Infectious Diseases Society of America (IDSA) in Washington DC. The
research results demonstrate that BAL30072 has especially potent in
vitro activity against Gram-negative bacilli such as Acinetobacter
and Pseudomonas aeruginosa that have acquired the reputation of
&quot;superbugs&quot; because of their high levels of resistance to many of the
currently marketed antibiotics.
]]></description>
		</item>
		<item>
			<title><![CDATA[DSM continues Partnership with Dutch Olympic Committee]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=233782</link>
			<pubDate>Fri, 24 Oct 2008 08:33:00 EDT</pubDate>
			<description><![CDATA[HEERLEN, NETHERLANDS--(eMediaWorld - October 24, 2008) - 

DSM and the Dutch Olympic Committee/Dutch Sports Federation (NOC*NSF)
will continue to be &#039;Partners in Sports&#039; in the run-up to the London
2012 Olympics. The partners have today signed an agreement to this
effect at the Papendal Dutch National Sports Centre. As innovation
partner of NOC*NSF, DSM is supporting the Dutch Olympic team with
innovations in the field of nutrition and materials in order to help
the team achieve top performances.
]]></description>
		</item>
		<item>
			<title><![CDATA[Price Increases Give Significant Boost to Dow Chemical&#039;s Quarterly Earnings, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=233783</link>
			<pubDate>Fri, 24 Oct 2008 07:15:00 EDT</pubDate>
			<description><![CDATA[SUGAR LAND, TX--(eMediaWorld - October 24, 2008) -  Researched by Industrial Info Resources
(Sugar Land, Texas) -- The Dow Chemical Company (NYSE:DOW) (Midland,
Michigan) released its earnings for the third quarter of fiscal year 2008
on October 23.  In the face of two hurricanes, rising energy and
transportation costs, and reduced product demand, Dow still managed to
raise its net income 6% from 3Q07, despite a 9% decrease in sales volume.
Sales volumes were down in four of Dow&#039;s six operating segments, but price
increases helped to increase income from sales.  Dow estimated that
hurricanes Ike and Gustav caused a loss of $127 million for the quarter.
]]></description>
		</item>
		<item>
			<title><![CDATA[Methanex Q3 Earnings Up 80% Over Second Quarter]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=231439</link>
			<pubDate>Wed, 22 Oct 2008 20:17:00 EDT</pubDate>
			<description><![CDATA[VANCOUVER, BRITISH COLUMBIA--(eMediaWorld - Oct. 22, 2008) - Methanex Corporation (TSX:MX)(NASDAQ:MEOH)(SANTIAGO:Methanex) - 

For the third quarter of 2008, Methanex reported Adjusted EBITDA(1) of $140.4 million and net income of $70.9 million ($0.75 per share on a diluted basis). This compares with Adjusted EBITDA(1) of $78.9 million and net income of $38.9 million ($0.41 per share on a diluted basis) for the second quarter of 2008.

Bruce Aitken, President and CEO of Methanex commented, &quot;Methanol prices remained strong in the third quarter and we achieved an average realized price of $413 per tonne. The stable price environment led to a significant improvement to our purchased methanol margins which contributed to significantly higher earnings.&quot;

]]></description>
		</item>
		<item>
			<title><![CDATA[Celanese Lowers 2008 Outlook After Posting $158 Million Profit as Economic Worries Grow, an Industrial Info News Alert]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=229008</link>
			<pubDate>Wed, 22 Oct 2008 05:30:00 EDT</pubDate>
			<description><![CDATA[SUGAR LAND, TX--(eMediaWorld - October 22, 2008) -  Researched by Industrial Info Resources
(Sugar Land, Texas) -- Celanese Corporation (NYSE:CE) (Dallas, Texas) has
lowered its outlook for the rest of the 2008 fiscal year, despite reporting
a third-quarter profit of $158 million, up 23.4% over the same period last
year. The revised outlook comes as the company faces the effects of the
global economic meltdown, as well as falling raw material and energy
prices, Chairman and CEO Dave Weidman said. As part of our International Project Database, Industrial Info is tracking
eight Celanese projects worth $178 million planned for completion in 2008
or beyond.
]]></description>
		</item>
		<item>
			<title><![CDATA[Biovitrum - Interim Report January 1 - September 30, 2008]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=229010</link>
			<pubDate>Wed, 22 Oct 2008 01:37:00 EDT</pubDate>
			<description><![CDATA[STOCKHOLM, SWEDEN--(eMediaWorld - October 22, 2008) - 

Strong financial third quarter. Product acquisition from Amgen paves
the way to expanded market platform


July - September

*           Net revenues amounted to SEK 294.2 M (199.8). The profit
  for the quarter was SEK 9.8 M (-22.5),
                corresponding to earnings per share of SEK -0.21
  (-0.49).

*           Cash flow from operations was SEK -25.5 M (-46.3). Cash
  and cash equivalents and short-term
                investments as of September 30 amounted to SEK 534.1
  M (805.3).

*           Biovitrum signed an agreement with Amgen to acquire
  Kepivance&reg; and Stemgen&reg; and an exclusive license
                for Kineret&reg;, paying a signing fee of USD 13 M.

*           A clinical study started of ExinaldaT, for the
  treatment of fat malabsorption in patients with cystic
                fibrosis.

*           The outlook for 2008, on the whole, remains unchanged,
  excluding cos]]></description>
		</item>
		<item>
			<title><![CDATA[Eurocontrol Announces Change to July 30, 2008 Private Placement Financing]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=229012</link>
			<pubDate>Tue, 21 Oct 2008 17:31:00 EDT</pubDate>
			<description><![CDATA[TORONTO, ONTARIO--(eMediaWorld - Oct. 21, 2008) - 

NOT FOR RELEASE IN THE UNITED STATES OR TO U.S. NEWS WIRE SERVICES

Eurocontrol Technics Inc. (TSX VENTURE:EUO), a Canadian public company specializing in the acquisition, development and commercialization of innovative authentication, verification and energy security technologies, wishes to revise the information issued in its July 30, 2008 press release in relation to the closing of its previously announced non-brokered private placement offering. The Offering was subject to TSX Venture approval and rather than 2,000,000 units at a price of $0.25 per unit for total gross proceeds of $500,000 having been approved and closed on, instead 1,360,000 units at a price of $0.25 per unit for total gross proceeds of $340,000 have been raised. Each unit was comprised of one common share of the Company and one common share purchase warrant. Each common share purchase warrant entitles the holder to acquire one common share in the capital of t]]></description>
		</item>
		<item>
			<title><![CDATA[China Shuangji Cement Receives Frankfurt Stock Exchange Listing]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=226499</link>
			<pubDate>Tue, 21 Oct 2008 07:30:00 EDT</pubDate>
			<description><![CDATA[ZHAOYUAN CITY, CHINA--(eMediaWorld - October 21, 2008) -  China Shuangji Cement Ltd. (OTCBB: CNSJ) (FRANKFURT: C99) (&quot;China Shuangji&quot; or &quot;the Company&quot;) wishes to
announce that it has received its listing effective today on the Frankfurt
Stock Exchange with the ticker symbol of &quot;C99.&quot; The approval of the listing
on the Frankfurt Stock Exchange is an important move in order to broaden
the Company&#039;s shareholder base and increase exposure to worldwide capital
markets which is an integral part of China Shuangji&#039;s international
strategy.
]]></description>
		</item>
		<item>
			<title><![CDATA[Crucell Doubles Production of Quinvaxem(R) in 2008 and Prepares Move to New Korean Production Site to Facilitate Growth]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=226500</link>
			<pubDate>Tue, 21 Oct 2008 05:11:00 EDT</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - October 21, 2008) - 

Dutch biopharma  company
Crucell N.V.  (Euronext, Nasdaq:  CRXL;  Swiss Exchange:  CRX)  today
announced that an agreement was reached to relocate Crucell&#039;s  Korean
production  facility,  where   its  pentavalent  children&#039;s   vaccine
Quinvaxem&reg; and a hepatitis B vaccine Hepavax-Gene&reg; are produced, from
the Shingal site in Yongin City,  Korea to the Incheon Free  Economic
Zone.

All parties involved have agreed on  the time line and conditions  of
this relocation, enabling a smooth  transition to the new  production
facility. With engineering well underway, construction activities  at
the new site are due to start soon. The new facility will enable  the
further  growth   and   efficient  production   of   Quinvaxem&reg;   and
Hepavax-Gene&reg;. No further details were provided.
]]></description>
		</item>
		<item>
			<title><![CDATA[DSM launches U.S. Department of Energy-funded research initiative for second generation biofuels]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=226501</link>
			<pubDate>Tue, 21 Oct 2008 01:26:00 EDT</pubDate>
			<description><![CDATA[HEERLEN, NETHERLANDS--(eMediaWorld - October 21, 2008) - 

Royal DSM N.V., the global Life Sciences and Materials Sciences
company today announced the execution of a multimillion dollar
cooperative funding agreement with the US Department of Energy to
underwrite a portion of research and development costs aimed at
enabling &quot;second generation&quot; biofuels from non-food feedstocks.

In February 2008, a consortium led by DSM that includes Abengoa
Bioenergy New Technologies, Los Alamos National Laboratory and Sandia
National Laboratory was awarded USD 7.4 million by the Department of
Energy toward a proposed USD 33 million program to conduct cost
effective enzyme development focused on finding applications in
cellulose-based biorefineries for the production of advanced biofuels
bio-based products. As part of its strategy to fully establish
industrial biotechnology as an alternative to traditional
petrochemical manufacturing, DSM has committed to funding the
majority of the project]]></description>
		</item>
		<item>
			<title><![CDATA[Basilea&#039;s Toctino(R) (alitretinoin) receives marketing authorization in France]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=226502</link>
			<pubDate>Tue, 21 Oct 2008 00:22:00 EDT</pubDate>
			<description><![CDATA[BASEL, SWITZERLAND--(eMediaWorld - October 21, 2008) - 

Basel, Switzerland, October 21, 2008 - Basilea Pharmaceutica Ltd.
announces that Toctino&reg; (alitretinoin), a new once-daily oral
treatment for adults with severe chronic hand eczema (CHE)
unresponsive to potent topical corticosteroids, has been approved by
the French Health Products Safety Agency (Agence Fran&ccedil;aise de
S&eacute;curit&eacute; Sanitaire des Produits de Sant&eacute; [AFSSAPS]).

Following the recommendation for regulatory approval under the
European decentralized procedure, Toctino&reg; has received national
regulatory approval in France. Basilea will submit a pricing and
reimbursement dossier to the French authorities based on the
approval.
]]></description>
		</item>
		<item>
			<title><![CDATA[Examine the China MPEG (Methoxy Polyethylene Glycol) Industry Report, 2008]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=224336</link>
			<pubDate>Mon, 20 Oct 2008 09:34:00 EDT</pubDate>
			<description><![CDATA[LONDON, UNITED KINGDOM--(eMediaWorld - Oct. 20, 2008) - Reportlinker.com announces that a new market research report related to the Chemicals industry is available in its catalogue.

China MPEG (Methoxy Polyethylene Glycol) Industry Report, 2008

http://www.reportlinker.com/p095601/China-MPEG-(Methoxy-Polyethylene-Glycol)-Industry-Report-2008.html

]]></description>
		</item>
		<item>
			<title><![CDATA[Basilea announces new data to be presented on ceftobiprole and isavuconazole at ICAAC/IDSA]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=223437</link>
			<pubDate>Mon, 20 Oct 2008 00:21:00 EDT</pubDate>
			<description><![CDATA[BASEL, SWITZERLAND--(eMediaWorld - October 20, 2008) - 

Basel, Switzerland, October 20, 2008 - New data on Basilea&#039;s
late-stage anti-infectives ceftobiprole and isavuconazole will be
presented at the upcoming joint meeting of the Annual Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the
Infectious Disease Society of America (IDSA) in Washington DC.

A series of more than twenty presentations related to ceftobiprole, a
broad-spectrum anti-MRSA cephalosporin antibiotic, will be discussed
at ICAAC/IDSA.
]]></description>
		</item>
		<item>
			<title><![CDATA[OCTOPLUS ANNOUNCES 2008 FIRST HALF-YEAR RESULTS AND PUBLICATION OF 2007 ANNUAL REPORT]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=219596</link>
			<pubDate>Thu, 16 Oct 2008 00:55:00 EDT</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - October 16, 2008) - 

OctoPlus N.V.  (&quot;OctoPlus&quot; or  &quot;the Company&quot;)  (Euronext: OCTO),  the
drug delivery company, announces today its results for the  six-month
period ended 30 June 2008. The Company also announces the publication
of its Annual Report 2007.

Financial and product highlights

- 30% increase in external revenues  for the six-month period from  EUR
2,874k in 2007 to EUR  3,738k in 2008

- Exclusive  license and  product acquisition  agreement signed  with
Biolex  Therapeutics  for  OctoPlus&#039;  lead  product  Locteron&reg;,  with
upfront and milestone payments up to US$ 149 million and royalties on
future Locteron sales, as well as a product supply and  manufacturing
agreement  signed  with  Biolex  for  the  further  development   and
manufacturing of Locteron
]]></description>
		</item>
		<item>
			<title><![CDATA[Raven Industries Included in Forbes 200 Best Small Companies]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=218954</link>
			<pubDate>Wed, 15 Oct 2008 15:54:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[SAFC Hitech(TM) Expands Electronic Materials Portfolio With the Introduction of Scintillation Crystal Growth Halides]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=218955</link>
			<pubDate>Wed, 15 Oct 2008 15:49:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Death of AgriTec Systems CEO]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=218976</link>
			<pubDate>Wed, 15 Oct 2008 15:49:00 EDT</pubDate>
			<description><![CDATA[WEBSTER, TEXAS--(eMediaWorld - Oct. 15, 2008) - AgriTec Systems Inc. (TSX VENTURE:AGR) (&quot;AgriTec&quot; or the &quot;Company&quot;) is sad to report the death of our CEO and President Douglas K. Stephens. Mr. Stephens began working for the Company&#039;s wholly owned subsidiary AgriTec Inc. in 1994. He became Vice President of AgriTec, Inc. in 1999 and President in 2001. He was named President and CEO of the newly formed AgriTec Systems Inc. in 2001 and was named to the Board of Directors in that same year. Mr. Stephens worked tirelessly to expand the Company&#039;s technology and business opportunities, which the Company will continue to develop domestically as well as internationally. He formed strong relationships that the Company has benefited from and will continue to rely on in this time of transition. His optimistic personality, dedication to the Company and friendship will be truly missed. A memorial service will be held Saturday, October 18, 2008 in Dickinson, Texas.
]]></description>
		</item>
		<item>
			<title><![CDATA[Oil-Dri Board of Directors Declares Dividends]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=218956</link>
			<pubDate>Wed, 15 Oct 2008 15:48:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Valspar Renews Share Repurchase Authorization]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=218957</link>
			<pubDate>Wed, 15 Oct 2008 15:30:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[China Agritech, Inc. Renews Sales Contract with China&#039;s Largest Fertilizer Distributor]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=218958</link>
			<pubDate>Wed, 15 Oct 2008 15:12:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Owens Corning to Announce 2008 Third-Quarter Results on Oct. 29]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=218442</link>
			<pubDate>Wed, 15 Oct 2008 12:45:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Air Products Announces Investments in Europe]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=218444</link>
			<pubDate>Wed, 15 Oct 2008 12:30:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Vector Intersect Security Acquisition Corporation Closes $4.75 Million Direct Investment By Catalyst Fund]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=218446</link>
			<pubDate>Wed, 15 Oct 2008 10:17:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Nivis and Apprion Collaborate on Products for the Next Generation of Open Industrial Wireless Networks]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=217159</link>
			<pubDate>Wed, 15 Oct 2008 07:00:00 EDT</pubDate>
			<description><![CDATA[ATLANTA, GA and MOFFETT FIELD, CA--(eMediaWorld - October 15, 2008) -  For immediate release:
Nivis, a global leader in the world of wireless industrial networks and
communications, and Apprion, the leader in providing open, integrated
industrial wireless systems for manufacturers, today announced that the two
companies will collaborate on providing industrial facilities with
reliable, secure wireless networks, devices, applications and services.

&quot;Our ingenious software coupled with Apprion&#039;s ION System creates a
remarkable synergism to benefit industrial customers,&quot; Marius O. Chilom,
CEO of Nivis, points out. &quot;This enables manufacturing plants to
cost-effectively and securely monitor just about every aspect of the
physical plant.&quot;
]]></description>
		</item>
		<item>
			<title><![CDATA[Poly-Pacific Announces Debt Settlement]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=217161</link>
			<pubDate>Wed, 15 Oct 2008 04:55:00 EDT</pubDate>
			<description><![CDATA[CALGARY, ALBERTA --(eMediaWorld - Oct. 15, 2008) - Poly-Pacific International Inc. (TSX VENTURE:PMB)(OTCBB:PLYPF)(BERLIN:A0LGDN)(FRANKFURT:POZ) (&quot;Poly-Pacific&quot; or the &quot;Company&quot;) is pleased to announce that it intends to settle outstanding indebtedness of up to $32,200 through the issuance of common shares (&quot;Shares&quot;) of the Company at a deemed price of $0.05 per Share (the &quot;Debt Settlement&quot;). The outstanding debt is comprised of salary obligations, consulting fees and other claims. If the entire Debt Settlement is completed 644,000 Shares will be issued. The Shares will be subject to a four month hold period upon issuance. 

]]></description>
		</item>
		<item>
			<title><![CDATA[BioSource Solutions Inc. Increases Sales Introducing 6 Eco-Certified Products Into One of the Largest Banner Grocery Chain Stores in Ontario, Canada]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=215829</link>
			<pubDate>Tue, 14 Oct 2008 15:21:00 EDT</pubDate>
			<description><![CDATA[ELMSDALE, NS--(eMediaWorld - October 14, 2008) -  BioSource Solutions Inc. (PINKSHEETS: BISL)
(FRANKFURT: BIA) -- a North American manufacturer of biodegradable,
biological, botanical consumer cleaning products --  has delivered its
first order of 6 Eco-Certified products to one of the largest and growing
food chain stores in Ontario, Canada. The grocery chain will carry Glass &amp;
Window Cleaner, Pet &amp; Stain Remover, Green Bin Deodorizer, All Purpose
Cleaner, Dish Detergent and Kitchen &amp; Bath Cleaner in more than 150 A&amp;P,
Dominion and Loeb store outlets.
]]></description>
		</item>
		<item>
			<title><![CDATA[Canexus to Hold Conference Call for Third Quarter Results]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=215830</link>
			<pubDate>Tue, 14 Oct 2008 14:42:00 EDT</pubDate>
			<description><![CDATA[CALGARY, ALBERTA--(eMediaWorld - Oct. 14, 2008) - Canexus Income Fund (TSX:CUS.UN) (the &quot;Fund&quot;) today announced it will hold a conference call to discuss its third quarter on Thursday, October 23, 2008, at 10 a.m. ET.

Gary Kubera, President and CEO, and Richard McLellan, Senior Vice President Finance and CFO, will discuss financial results and performance for the period ended September 30, 2008. The results will be released before the call.

To access the call, please dial 416-644-3414 or 1-800-732-6179. The conference call will also be accessible via webcast at www.canexus.ca.

]]></description>
		</item>
		<item>
			<title><![CDATA[Libbey Declares Regular Quarterly Cash Dividend]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=215823</link>
			<pubDate>Tue, 14 Oct 2008 14:04:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Color Sealants in the Field with Bondaflex(R) Ucolor(R)]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=215824</link>
			<pubDate>Tue, 14 Oct 2008 12:56:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Kronos Worldwide, Inc. Announces a Price Increase for All Titanium Dioxide Products Sold in Europe and Eastern Europe]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=215825</link>
			<pubDate>Tue, 14 Oct 2008 09:23:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Tootoo.com: Price of Chinese Ink Boxes to Increase due to Raising Oil Price]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=215826</link>
			<pubDate>Tue, 14 Oct 2008 09:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=215827</link>
			<pubDate>Tue, 14 Oct 2008 06:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Atraverda Appoints New Vice President for North America]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=215828</link>
			<pubDate>Tue, 14 Oct 2008 06:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[American Pacific to Hold Teleconference Regarding Acquisition of Marotta Europe for 4.7 Million Euros]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=214017</link>
			<pubDate>Mon, 13 Oct 2008 18:53:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[ScottsMiracle-Gro Schedules Release of Fourth Quarter 2008 Financial Results; Conference Call with Investors on Friday, October 31]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=214018</link>
			<pubDate>Mon, 13 Oct 2008 15:40:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Saint-Gobain Acquires Soundproofing Plastics Manufacturer]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=213485</link>
			<pubDate>Mon, 13 Oct 2008 12:50:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Texas Petrochemicals Announces 2008 Annual Meeting of Stockholders]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=213486</link>
			<pubDate>Mon, 13 Oct 2008 12:03:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Lubrizol Expands Estane(R) Engineered Polymers Product Offerings]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=212979</link>
			<pubDate>Mon, 13 Oct 2008 09:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Senscient ELDS(TM) Series Open Path Gas Detectors Eliminate False Alarms Inherent in Conventional Designs]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=213003</link>
			<pubDate>Mon, 13 Oct 2008 08:00:00 EDT</pubDate>
			<description><![CDATA[LEAGUE CITY, TX--(eMediaWorld - October 13, 2008) -  An industry first, Senscient&#039;s new ELDS
Series Open Path Gas Detectors (OPGDs) feature truly false-alarm free
flammable and toxic gas detection.  ELDS gas detectors, scheduled to begin
shipping in the first quarter of 2009, solve a problem common in the oil
and gas industry: unreliable readings causing false alarms that cost
millions of dollars in lost revenue annually.  Safety systems triggered by
the detection of potentially hazardous gases typically shut down processes
and facilities to prevent catastrophe.  But when a false alarm triggers the
system, productivity is lost while the alarm origin is investigated, false
alarm status is verified, and processes are slowly brought back on line.
]]></description>
		</item>
		<item>
			<title><![CDATA[Katy Industries, Inc. Announces Reverse Stock Split and Plan to Deregister]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=211653</link>
			<pubDate>Fri, 10 Oct 2008 15:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[NuView Life Sciences Inc. Assumes Management of Trace Life Sciences Inc. Radioisotope Production Facility]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=211654</link>
			<pubDate>Fri, 10 Oct 2008 14:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Elemica &amp;amp; JFE Systems Partner to Support Japan Market]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=210609</link>
			<pubDate>Fri, 10 Oct 2008 07:15:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Webcast Alert: AMCOL International Corporation (NYSE: ACO) Announces 3rd Quarter 2008 Earnings]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=210610</link>
			<pubDate>Fri, 10 Oct 2008 06:45:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[OctoPlus announces dates for AGM and for publication of 2007 annual report and 2008 half-year results]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=210644</link>
			<pubDate>Fri, 10 Oct 2008 00:45:00 EDT</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - October 10, 2008) - 

OctoPlus N.V. (&quot;OctoPlus&quot; or the &quot;Company&quot;) (Euronext: OCTO), the
drug delivery company, announces today the publication date for its
Annual Report 2007 and its results for the six-month period ended 30
June 2008, and the date for its Annual General Meeting of
Shareholders (AGM).

- Thursday 16 October: publication of Annual Report 2007 and the
results for the first half-year of 2008

- Thursday 6 November: Annual General Meeting of Shareholders in
Leiden.
]]></description>
		</item>
		<item>
			<title><![CDATA[ABLYNX PROVIDES AN R&amp;D UPDATE ANNOUNCING IT HAS SUCCESSFULLY GENERATED NANOBODIES(R) AGAINST GPCRs AND PRESENTS NEW PRECLINICAL DEVELOPMENT RANKL PROGRAMME]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=210645</link>
			<pubDate>Fri, 10 Oct 2008 00:36:00 EDT</pubDate>
			<description><![CDATA[GHENT, BELGIUM--(eMediaWorld - October 10, 2008) -  Ablynx [Euronext Brussels:  ABLX],
a pioneer in the  discovery and development  of Nanobodies&reg;, a  novel
class of antibody-derived  therapeutic proteins,  announced today  it
has  successfully   generated   Nanobodies&reg;  against   several   GPCR
receptors. Furthermore, Ablynx will present  during its R&amp;D update in
Ghent today, its  new preclinical development  programme ALX-0141,  a
Nanobody&reg; against  Receptor  Activator  for Nuclear  Factor  kappa  B
Ligand (RANKL),  an  important  target for  bone  disorders  such  as
osteoporosis. The Company also provided an update on the  significant
progress made  of its  Nanobody&reg; therapeutic  pipeline and  Nanobody&reg;
technology platform.
]]></description>
		</item>
		<item>
			<title><![CDATA[Merck Serono Named as a Top Employer by Science Magazine]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=210611</link>
			<pubDate>Fri, 10 Oct 2008 00:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Braskem Issues US$ 725 Million Export Prepayment Facility]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=210612</link>
			<pubDate>Thu, 09 Oct 2008 15:52:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Mosaic Announces Quarterly Dividend of $0.05 Per Share]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=210613</link>
			<pubDate>Thu, 09 Oct 2008 15:24:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Monsanto Recognized as Top Biotechnology Employer by Science Magazine]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=210615</link>
			<pubDate>Thu, 09 Oct 2008 15:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Senscient ELDS(TM) Series 2000 H2S+CH4 Open Path Gas Detector Simultaneously Detects Methane &amp; Hydrogen Sulfide Gas]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=209831</link>
			<pubDate>Thu, 09 Oct 2008 10:29:00 EDT</pubDate>
			<description><![CDATA[LEAGUE CITY, TX--(eMediaWorld - October 9, 2008) -  Senscient&#039;s new ELDS Series 2000 H2S+CH4
open path gas detector (OPGDs) features the company&#039;s patented Enhanced
Laser Diode Spectroscopy (ELDS) technology for increased sensitivity,
simultaneous multi-gas detection capability, and remote electronic
functionality confirmation. An industry first, Senscient&#039;s new ELDS Series
Open Path Gas Detectors (OPGDs) feature truly false-alarm free, low ppm
detection of both flammable and toxic gases.

Using a separate transmitter and receiver configuration, ELDS Series 2000
dual laser systems measure a Harmonic FingerprintT introduced onto the
transmitter&#039;s laser beam(s) by absorption of the target gas(es) in the
monitored path. &quot;Our ultra-sensitive ELDS technology provides the operator
with the earliest warning response of any other gas detection technology
for safety applications on the market today, providing precious time for
remedial action to shut down plant processes and evacuate]]></description>
		</item>
		<item>
			<title><![CDATA[Court to Notify West Virginians - Who Lived in the Nitro or St. Albans Area During the Tire Fire in May 2006 - About a Class Action Settlement]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=209324</link>
			<pubDate>Thu, 09 Oct 2008 09:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Newell Rubbermaid to Webcast Third Quarter 2008 Earnings Results]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=209325</link>
			<pubDate>Thu, 09 Oct 2008 07:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Court Enters Order Approving the Sale of the Plastics Films and Molded Products Businesses of Atlantis Plastics, Inc.]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=208141</link>
			<pubDate>Wed, 08 Oct 2008 16:09:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Z Trim R&amp;amp;D Team Develops Cost-Effective Solution for Food Designers Seeking Starch Reduction and Clean Labels]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=207548</link>
			<pubDate>Wed, 08 Oct 2008 10:27:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Red Reef Laboratories International, Inc. (RRLB PK) Announces MyoTrend Nutritional Technologies Distribution Agreement in Europe]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=206653</link>
			<pubDate>Wed, 08 Oct 2008 07:30:00 EDT</pubDate>
			<description><![CDATA[DEERFIELD BEACH, FL and NAPOLEONVILLE, LA and WEXFORD, PA--(eMediaWorld - October 8, 2008) - 
Red Reef Laboratories International, Inc. (PINKSHEETS: RRLB), a diversified
scientific research, development, and marketing group, and MyoTrend
Nutritional Technologies, LLC (MNT), a wholly owned subsidiary, announce
that MyoTrend has entered into an exclusive distribution agreement with
Europe&#039;s leader in Sports Nutrition, NutriWorld Group B.V. (NutriWorld)
(www.nutriworld.nl).
]]></description>
		</item>
		<item>
			<title><![CDATA[Fuwei Films Announces Final Results of the Anti-Dumping Investigation Conducted by the U.S. Department of Commerce]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=206613</link>
			<pubDate>Wed, 08 Oct 2008 05:52:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Monsanto Company&#039;s Webcast and Analyst/Media Call for 2008 Fourth-Quarter and Fiscal-Year Financial Results Set for Tomorrow]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=205208</link>
			<pubDate>Tue, 07 Oct 2008 12:44:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Termites Lurking Year-Round Pose Significant Threat to Homeowners]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=204462</link>
			<pubDate>Tue, 07 Oct 2008 04:20:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[PolyOne Announces the Lifting of Force Majeure from the SunBelt Chlor Alkali Partnership]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=203182</link>
			<pubDate>Mon, 06 Oct 2008 18:03:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Huntsman Announces 2008 Annual Meeting]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=203183</link>
			<pubDate>Mon, 06 Oct 2008 16:57:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Sunair Services Corporation Sells Telecom FM Limited]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=203184</link>
			<pubDate>Mon, 06 Oct 2008 16:56:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[RPM Announces Form 4 Filings]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=203185</link>
			<pubDate>Mon, 06 Oct 2008 16:39:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Court Enters Order Approving AEP Industries Inc.&#039;s Acquisition of Plastic Films Segment of Atlantis Plastics, Inc.]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=203186</link>
			<pubDate>Mon, 06 Oct 2008 16:10:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Universal Systems and Atlas Monetary International Trust Complete Joint Venture Agreement]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=201515</link>
			<pubDate>Mon, 06 Oct 2008 08:00:00 EDT</pubDate>
			<description><![CDATA[BAKER CITY, OR--(eMediaWorld - October 6, 2008) -  Universal Systems, Inc. (PINKSHEETS: UVSS)
is pleased to announce today that it has successfully signed a joint
venture agreement with Atlas Monetary International Trust. The agreement
encompasses several initiatives that are core to the Atlas mission.  The
first component of the agreement has been defined and awards to USI a
contract for the design and production of a marine system for cleaning
petroleum spills at the point of the spill.  USI was selected by Atlas
Trust for this joint venture based on the performance of its
electro-coagulation systems and the environmental focus of the corporation.
The patented technologies employed in these systems give them unrivaled
volume flow performance and the ability to remove even the smallest traces
of petroleum and other contaminants from seawater, potentially leaving it
cleaner than it was before the spill.  Discussions ]]></description>
		</item>
		<item>
			<title><![CDATA[Learn about the US Sealants and Caulks Market]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=201516</link>
			<pubDate>Mon, 06 Oct 2008 06:40:00 EDT</pubDate>
			<description><![CDATA[LONDON, UNITED KINGDOM--(eMediaWorld - Oct. 6, 2008) - Reportlinker.com announces that a new market research report related to the Chemicals industry industry is available in its catalogue.

US Sealants and Caulks Market

http://www.reportlinker.com/p096401/US-Sealants-and-Caulks-Market.html

US demand to grow 2.8% annually through 2012

]]></description>
		</item>
		<item>
			<title><![CDATA[Learn About the US Engineering Plastics Market]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=201517</link>
			<pubDate>Mon, 06 Oct 2008 06:16:00 EDT</pubDate>
			<description><![CDATA[LONDON, UNITED KINGDOM--(eMediaWorld - Oct. 6, 2008) - Reportlinker.com announces that a new market research report related to the Plastic industry industry is available in its catalogue.

US Engineering Plastics Market

http://www.reportlinker.com/p096498/US-Engineering-Plastics-Market.html

US demand to rise 3.1% annually through 2012 

]]></description>
		</item>
		<item>
			<title><![CDATA[China Agritech, Inc. Retains Grayling Global as Strategic Investor Relations Consultant]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=201569</link>
			<pubDate>Mon, 06 Oct 2008 05:52:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[University of KwaZulu-Natal Physicists Make History in Establishing Durban as the World&#039;s First Quantum City]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=201570</link>
			<pubDate>Mon, 06 Oct 2008 02:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[OctoPlus announces exclusive license and manufacturing agreement for Locteron with Biolex allowing for revenues in excess of 100 million euro]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=201518</link>
			<pubDate>Mon, 06 Oct 2008 00:51:00 EDT</pubDate>
			<description><![CDATA[LEIDEN, NETHERLANDS--(eMediaWorld - October 6, 2008) - 

This agreement will immediately transform OctoPlus into a cashflow
positive company

OctoPlus N.V. (&quot;OctoPlus&quot; or the &quot;Company&quot;) (Euronext: OCTO), the
drug delivery company, announces today that it has signed an
exclusive license and product acquisition agreement to license its
share of the commercial rights to its lead product Locteron&reg; to
co-development partner Biolex Therapeutics. OctoPlus will remain a
partner in the process development and manufacture of Locteron, but
without having to make the investments for the upcoming late-stage
clinical program. The proceeds of the agreement include among others
upfront and milestone payments that amount to a total of US$ 149
million (EUR  108 million) in the coming years, and royalties on future
Locteron sales. The upfront fee and short-term milestone payments
comprise the first significant revenues that OctoPlus generates from
the commercialisation of its drug delive]]></description>
		</item>
		<item>
			<title><![CDATA[Basilea&#039;s Toctino(R) (alitretinoin) receives marketing authorization in Germany]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=201519</link>
			<pubDate>Mon, 06 Oct 2008 00:21:00 EDT</pubDate>
			<description><![CDATA[BASEL, SWITZERLAND--(eMediaWorld - October 6, 2008) - 

Basel, Switzerland, October 6, 2008 - Basilea Pharmaceutica Ltd.
announces that Toctino&reg; (alitretinoin), a new once-daily oral
treatment for adults with severe chronic hand eczema (CHE)
unresponsive to potent topical corticosteroids, has been approved by
the German health authority &quot;Bundesinstitut f&uuml;r Arzneimittel und
Medizinprodukte&quot; (BfArM).

Following the recommendation for regulatory approval under the
European decentralized procedure, Toctino&reg; received national
regulatory approval in Germany.
]]></description>
		</item>
		<item>
			<title><![CDATA[JER Envirotech Announces Management Resignation]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=200559</link>
			<pubDate>Fri, 03 Oct 2008 17:46:00 EDT</pubDate>
			<description><![CDATA[VANCOUVER, BC--(eMediaWorld - October 3, 2008) -  JER Envirotech International Corp. (TSX-V: JER) (FRANKFURT: KFTB) (&quot;JER&quot;) wishes to announce that Mark Komonoski has
resigned from the position of Senior Vice President of Investor Relations.
&quot;JER is committed to reaching profitability and cost containment will
contribute to achieving this goal.  I would like to thank Mark for his high
level of professionalism and integrity.  His contribution to our business
in the area of investor relations has been excellent,&quot; said Edward Trueman,
President and CEO.    &quot;Given the difficult market conditions for a
technology development company, Mark&#039;s performance was excellent. His
initiatives with the investment community helped JER have enough public
market interest to raise over $11 million in working and development
capital over the past two years.&quot;
]]></description>
		</item>
		<item>
			<title><![CDATA[Air Products, Drexel University and Shanghai Jiao Tong University Agree to Continue Unique &#039;3-2 Program&#039; for Exceptional Chinese Students]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=200365</link>
			<pubDate>Fri, 03 Oct 2008 13:54:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Vector Intersect Security Acquisition Corporation Announces Record Date and Meeting Date for Stockholder Vote]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=199198</link>
			<pubDate>Fri, 03 Oct 2008 09:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Business Continuity Process Helps Goodyear Minimize Hurricane Impact]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=199199</link>
			<pubDate>Fri, 03 Oct 2008 08:56:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Filtrona Acquires Lendell Manufacturing]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=199202</link>
			<pubDate>Fri, 03 Oct 2008 07:30:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[ABLYNX IS AWARDED EUR 1.8 MILLION GRANT TO EXPLORE NOVEL METHODS FOR USES OF NANOBODIES(R)]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=198731</link>
			<pubDate>Fri, 03 Oct 2008 00:30:00 EDT</pubDate>
			<description><![CDATA[GHENT, BELGIUM--(eMediaWorld - October 3, 2008) - 

GHENT, Belgium, 3 October 2008 - Ablynx [Euronext Brussels: ABLX],  a
pioneer in  the discovery  and development  of Nanobodies&reg;,  a  novel
class of antibody-derived therapeutic proteins, today announced  that
it has been awarded a grant  worth EUR 1.8 million by the Institute  for
the Promotion of  Innovation by  Science and  Technology in  Flanders
(IWT).

Nanobodies&reg; are  a  new  class  of  therapeutic  proteins  comprising
naturally-occurring single  domain antibodies.  The grant,  which  is
over three  years,  allows  Ablynx to  further  develop  technologies
related to  its  Nanobody&reg;  platform. Furthermore,  this  grant  will
enable Ablynx to expand its intellectual property portfolio.
]]></description>
		</item>
		<item>
			<title><![CDATA[Tronox Announces Surcharge for Titanium Dioxide Grades Sold in North American Paper Market]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=199203</link>
			<pubDate>Thu, 02 Oct 2008 17:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[FTC Ends Waiting Period for Huntsman/Hexion Merger]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=199204</link>
			<pubDate>Thu, 02 Oct 2008 16:29:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Cold Jet Report: Nearly Half of Packaging Companies Have Produced Inferior Quality Products Due to Poor Cleaning Practices]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=197518</link>
			<pubDate>Thu, 02 Oct 2008 10:32:00 EDT</pubDate>
			<description><![CDATA[Industrial Cleaning Habits and Practices Report Provides Insights Into Cleaning Practices of Organizations in the Packaging Industry]]></description>
		</item>
		<item>
			<title><![CDATA[Monsanto Increases 2008 Earnings-Per-Share Guidance, With Growth Continuing From the Company&#039;s Seeds-and-Traits and Roundup Businesses]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=197507</link>
			<pubDate>Thu, 02 Oct 2008 10:24:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[CryoPort Inc. Begins Shipping Samples for DuPont Crop Protection]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=196922</link>
			<pubDate>Thu, 02 Oct 2008 09:10:00 EDT</pubDate>
			<description><![CDATA[Shipment Represents New Market for the CryoPort Express(TM) Shipper]]></description>
		</item>
		<item>
			<title><![CDATA[Monsanto Company Completes Sale of POSILAC Bovine Somatotropin and Related Business]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=196992</link>
			<pubDate>Thu, 02 Oct 2008 08:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[RPM Adjusts Full-Year Guidance]]></title>
			<link>http://www.emediaworld.com/press_release/release_detail.php?id=196995</link>
			<pubDate>Thu, 02 Oct 2008 08:00:00 EDT</pubDate>
			<description><![CDATA[]]></description>
		</item>
		<item>
			<title><![CDATA[Nanophase Announces New Executive Positions; Strategic Organizational Realignment]]></title>
			<link>http://www.emediaworld.com/press_release/release_detai